{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "2b21090e",
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import Any, Dict\n",
    "\n",
    "from google.adk.agents import Agent, LlmAgent\n",
    "from google.adk.apps.app import App, EventsCompactionConfig\n",
    "from google.adk.models.google_llm import Gemini\n",
    "from google.adk.sessions import DatabaseSessionService\n",
    "from google.adk.sessions import InMemorySessionService\n",
    "from google.adk.runners import Runner\n",
    "from google.adk.tools.tool_context import ToolContext\n",
    "from google.genai import types\n",
    "import os\n",
    "import asyncio"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "8c896da9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Authentication & API setup completed.\n"
     ]
    }
   ],
   "source": [
    "try:\n",
    "  GOOGLE_API_KEY = os.getenv(\"GOOGLE_API_KEY\")\n",
    "  print(\"Authentication & API setup completed.\")\n",
    "except Exception as e:\n",
    "  print(f\"Errror: {e}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "e7ca961e",
   "metadata": {},
   "outputs": [],
   "source": [
    "# retry_options\n",
    "\n",
    "retry_config = types.HttpRetryOptions(\n",
    "  attempts=5,\n",
    "  initial_delay=1,\n",
    "  exp_base=7,\n",
    "  http_status_codes=[429,500,503,504]\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f048fcea",
   "metadata": {},
   "source": [
    "### Helper function\n",
    "\n",
    "Helper function that manages a complete conversation session, handling session\n",
    "creation/retrieval, query processing, and response streaming. It supports\n",
    "both single queries and multiple queries in sequence.\n",
    "\n",
    "Example:\n",
    "\n",
    "```\n",
    ">>> await run_session(runner, \"What is the capital of France?\", \"geography-session\")\n",
    ">>> await run_session(runner, [\"Hello!\", \"What's my name?\"], \"user-intro-session\")\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "3a8eb48e",
   "metadata": {},
   "outputs": [],
   "source": [
    "async def run_session(\n",
    "    runner_instance: Runner,\n",
    "    user_queries: list[str] | str = None,\n",
    "    session_name : str =\"default\"\n",
    "\n",
    "):\n",
    "  print(f\"\\n ### SESSION: {session_name}\")\n",
    "\n",
    "  #Get APP name from the Runner\n",
    "  app_name = runner_instance.app_name\n",
    "\n",
    "  #Attempt to create a new session or retrieve an existing one\n",
    "  try:\n",
    "    session = await session_service.create_session(\n",
    "      app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "    )\n",
    "  except:\n",
    "    session= await session_service.get_session(\n",
    "      app_name=app_name,user_id =USER_ID,session_id=session_name\n",
    "    )\n",
    "\n",
    "  #Process queries if provided\n",
    "  if user_queries:\n",
    "    #convert single query to list for uniform processing\n",
    "    if type(user_queries)==str:\n",
    "      user_queries=[user_queries]\n",
    "\n",
    "    #Process each query in the list sequentially\n",
    "    for query in user_queries:\n",
    "      print(f\"\\n User > {query}\")\n",
    "\n",
    "      #Convert the query string to the ADK content format\n",
    "      query=types.Content(role=\"user\",parts=[types.Part(text=query)])\n",
    "\n",
    "      #stream the agents response asynchronously\n",
    "      async for event in runner_instance.run_async(\n",
    "        user_id=USER_ID, session_id=session.id, new_message=query\n",
    "      ):\n",
    "        #check if the event contains valid content\n",
    "        if event.content and event.content.parts:\n",
    "          #filter out empty of None responses before printing\n",
    "          if(\n",
    "            event.content.parts[0].text !=\"None\"\n",
    "            and event.content.parts[0].text\n",
    "          ):\n",
    "            print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n",
    "  else:\n",
    "    print(\"No queries!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "dcf2da51",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"default\", but the root agent was loaded from \"/Users/liakooras/Desktop/UDEMIES/genAiKaggle/.conda/lib/python3.12/site-packages/google/adk/agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Stateful agent initialized!\n",
      "   - Application: default\n",
      "   - User: default\n",
      "   - Using: InMemorySessionService\n"
     ]
    }
   ],
   "source": [
    "# Implementing Stateful Agent\n",
    "#he can remember and have constructive conversations.\n",
    "\n",
    "APP_NAME = \"default\" #Application\n",
    "USER_ID = \"default\" #User\n",
    "SESSION = \"default\" #Session\n",
    "MODEL_NAME = \"gemini-2.5-flash-lite\"\n",
    "\n",
    "#step1 :create llm agent\n",
    "\n",
    "root_agent = Agent(\n",
    "  model=Gemini(model=MODEL_NAME,retry_options=retry_config),\n",
    "  name=\"text_chat_bot\",\n",
    "  description=\"A text chatbot\", #description of the agents purpose\n",
    ")\n",
    "\n",
    "#Step2: set up session management\n",
    "#InMemorySessionService stores conversations in RAM temporary.\n",
    "\n",
    "session_service = InMemorySessionService()\n",
    "\n",
    "#Step3: create the runner\n",
    "runner=Runner(agent=root_agent,app_name=APP_NAME,session_service=session_service)\n",
    "\n",
    "print(\"Stateful agent initialized!\")\n",
    "print(f\"   - Application: {APP_NAME}\")\n",
    "print(f\"   - User: {USER_ID}\")\n",
    "print(f\"   - Using: {session_service.__class__.__name__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "0ef09f48",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### SESSION: stateful-agentic-session\n",
      "\n",
      " User > Hi,Im Ilias, whats the climate change Risk?\n",
      "gemini-2.5-flash-lite >  Hi Ilias! It's great to meet you.\n",
      "\n",
      "Climate change risk refers to the **potential for negative impacts and losses that arise from the changing climate**. It's not just about the weather getting warmer, but about the wide-ranging consequences that this warming can have on our planet and on human society.\n",
      "\n",
      "Here's a breakdown of what climate change risk entails:\n",
      "\n",
      "**1. Physical Risks:** These are the direct impacts of a changing climate on the environment and natural systems. They include:\n",
      "\n",
      "*   **Extreme Weather Events:** More frequent and intense heatwaves, droughts, floods, storms (hurricanes, typhoons), wildfires, and heavy rainfall.\n",
      "*   **Sea Level Rise:** Leading to coastal flooding, erosion, and saltwater intrusion into freshwater sources.\n",
      "*   **Changes in Precipitation Patterns:** Causing water scarcity in some regions and increased flooding in others.\n",
      "*   **Ocean Acidification:** Harming marine ecosystems, particularly coral reefs and shellfish.\n",
      "*   **Biodiversity Loss:** As ecosystems struggle to adapt to changing conditions, many species face extinction.\n",
      "\n",
      "**2. Transition Risks:** These risks arise from the process of moving towards a lower-carbon economy. They can include:\n",
      "\n",
      "*   **Policy and Legal Risks:** New regulations, carbon pricing mechanisms, and potential litigation against polluters.\n",
      "*   **Technology Risks:** The disruption caused by the development and adoption of new, cleaner technologies, potentially making existing ones obsolete.\n",
      "*   **Market Risks:** Changes in consumer preferences, investor sentiment, and the availability of certain goods and services due to climate change.\n",
      "*   **Reputation Risks:** Companies and organizations facing backlash or damage to their brand if they are perceived as not acting on climate change.\n",
      "\n",
      "**3. Societal Risks:** These are the impacts on human well-being, economies, and social systems. They can include:\n",
      "\n",
      "*   **Impacts on Human Health:** Increased heat-related illnesses, spread of infectious diseases, respiratory problems from air pollution, and mental health impacts from extreme events.\n",
      "*   **Food and Water Security:** Disruptions to agricultural production, leading to shortages and price volatility. Water scarcity can also become a major issue.\n",
      "*   **Economic Disruption:** Damage to infrastructure, loss of productivity, increased disaster relief costs, and impacts on industries like tourism and agriculture.\n",
      "*   **Displacement and Migration:** As areas become uninhabitable due to sea-level rise or resource scarcity, people may be forced to relocate.\n",
      "*   **Increased Inequality:** Vulnerable populations often bear a disproportionate burden of climate change impacts.\n",
      "*   **Geopolitical Instability:** Competition for dwindling resources like water and arable land can exacerbate existing tensions and lead to conflict.\n",
      "\n",
      "**In essence, climate change risk is about the probability and severity of these adverse outcomes occurring.** It's a complex issue because the impacts are interconnected and can have cascading effects. Understanding these risks is crucial for individuals, businesses, and governments to develop strategies for mitigation (reducing greenhouse gas emissions) and adaptation (adjusting to the changes that are already happening or are unavoidable).\n",
      "\n",
      "Do you have any specific aspects of climate change risk you'd like to explore further, Ilias? For example, are you interested in the risks to a particular region, industry, or aspect of life?\n",
      "\n",
      " User > Whats my name?\n",
      "gemini-2.5-flash-lite >  Your name is Ilias.\n"
     ]
    }
   ],
   "source": [
    "### Testing the Stateful agent\n",
    "await run_session(\n",
    "  runner,\n",
    "  [\n",
    "    \"Hi,Im Ilias, whats the climate change Risk?\",\n",
    "    \"Whats my name?\",#this time , the agent should remember\n",
    "  ],\n",
    "  \"stateful-agentic-session\"\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8e03186a",
   "metadata": {},
   "source": [
    "#### Restarting the kernel, the agent wont remember anything"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "f4a16885",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### SESSION: stateful-agentic-session\n",
      "\n",
      " User > What did I ask you about earlier?\n",
      "gemini-2.5-flash-lite >  Earlier, you asked me about \"the climate change Risk\".\n",
      "\n",
      " User > And remind me, what's my name?\n",
      "gemini-2.5-flash-lite >  Your name is Ilias.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n",
    "    \"stateful-agentic-session\",\n",
    ")   #Note, we are using same session name"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "86e4f704",
   "metadata": {},
   "source": [
    "Persistent Sessions with `DatabaseSessionService`\n",
    "\n",
    "While `InMemorySessionService` is great for prototyping, real-world applications need conversations to survive restarts, crashes, and deployments. Let's level up to persistent storage!\n",
    "\n",
    "### 3.1 Choosing the Right SessionService\n",
    "\n",
    "ADK provides different SessionService implementations for different needs:\n",
    "\n",
    "| Service | Use Case | Persistence | Best For |\n",
    "|---------|----------|-------------|----------|\n",
    "| **InMemorySessionService** | Development & Testing | ❌ Lost on restart | Quick prototypes |\n",
    "| **DatabaseSessionService** | Self-managed apps | ✅ Survives restarts | Small to medium apps |\n",
    "| **Agent Engine Sessions** | Production on GCP | ✅ Fully managed | Enterprise scale |\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "39888c1a",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"default\", but the root agent was loaded from \"/Users/liakooras/Desktop/UDEMIES/genAiKaggle/.conda/lib/python3.12/site-packages/google/adk/agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Upgraded to persistent sessions!\n",
      "   - Database: my_agent_data.db\n",
      "   - Sessions will survive restarts!\n"
     ]
    }
   ],
   "source": [
    "# Step 1: Create the same agent (notice we use LlmAgent this time)\n",
    "chatbot_agent = LlmAgent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"A text chatbot with persistent memory\",\n",
    ")\n",
    "\n",
    "# Step 2: Switch to DatabaseSessionService\n",
    "# SQLite database will be created automatically\n",
    "db_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\n",
    "session_service = DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "# Step 3: Create a new runner with persistent storage\n",
    "runner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n",
    "\n",
    "print(\" Upgraded to persistent sessions!\")\n",
    "print(f\"   - Database: my_agent_data.db\")\n",
    "print(f\"   - Sessions will survive restarts!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "03e3ba6f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### SESSION: test-db-session-02\n",
      "\n",
      " User > Whats my name?\n",
      "gemini-2.5-flash-lite >  I do not have access to your personal information, including your name. I am a text chatbot with persistent memory, but my memory is limited to our conversation history. I cannot access external data or user accounts.\n"
     ]
    }
   ],
   "source": [
    "#verifying that the session data is isolated\n",
    "await run_session(\n",
    "  runner,[\"Whats my name?\"],\"test-db-session-02\"\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "65857763",
   "metadata": {},
   "source": [
    "### How events are stored in the Database\n",
    "\n",
    "Using sqlite DB to store information"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "56f5b508",
   "metadata": {},
   "outputs": [],
   "source": [
    "import sqlite3\n",
    "\n",
    "def check_data_in_db():\n",
    "  with sqlite3.connect(\"my_agent.db\") as connection:\n",
    "    cursor = connection.cursor()\n",
    "    result = cursor.execute(\n",
    "      \"select app_name, session_id, author, content from events\"\n",
    "    )\n",
    "    print(i[0] for i in result.description)\n",
    "    for result in result.fetchall():\n",
    "      print(result)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "79cf1888",
   "metadata": {},
   "source": [
    "How the events are stored in the database\n",
    "\n",
    "['app_name', 'session_id', 'author', 'content']\n",
    "\n",
    "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n",
    "\n",
    "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n",
    "\n",
    "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
    "\n",
    "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n",
    "\n",
    "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n",
    "\n",
    "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n",
    "\n",
    "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
    "\n",
    "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n",
    "\n",
    "('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
    "\n",
    "('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. I am a large language model, trained by Google.\"}], \"role\": \"model\"}')\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "79eb92a0",
   "metadata": {},
   "source": [
    "### ADKs Context Compaction(ADK's default compaction) to automatically reduce the context that's stored in the Session.\n",
    "\n",
    "**`EventsCompactionConfig`** defines two key variables:\n",
    "\n",
    "- **compaction_interval**: Asks the Runner to compact the history after every `n` conversations\n",
    "- **overlap_size**: Defines the number of previous conversations to retain for overlap"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "f9ca7f9c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/kw/6d_1c0rj22d1pqvkf0fldhlm0000gn/T/ipykernel_56024/3425662949.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n",
      "  events_compaction_config=EventsCompactionConfig(\n",
      "App name mismatch detected. The runner is configured with app name \"research_app_compacting\", but the root agent was loaded from \"/Users/liakooras/Desktop/UDEMIES/genAiKaggle/.conda/lib/python3.12/site-packages/google/adk/agents\", which implies app name \"agents\".\n"
     ]
    }
   ],
   "source": [
    "#re-define the app with Events Compaction enabled\n",
    "research_app_compacting = App(\n",
    "  name = \"research_app_compacting\",\n",
    "  root_agent=chatbot_agent,\n",
    "  #this is the new part!\n",
    "  events_compaction_config=EventsCompactionConfig(\n",
    "    compaction_interval=3, #Trigger Compaction eveny 3 invocations\n",
    "    overlap_size=1, #keep 1 previous turn for context\n",
    "  ),\n",
    ")\n",
    "\n",
    "db_url= \"sqlite:///my_agent_data.db\"\n",
    "session_service=DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "#Create a new runner for the upgraded app\n",
    "research_runner_compacting = Runner(\n",
    "  app=research_app_compacting, session_service=session_service\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "18832a4c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### SESSION: compaction_demo\n",
      "\n",
      " User > What is the latest news about AI in healthcare?\n",
      "gemini-2.5-flash-lite >  The field of AI in healthcare is rapidly evolving, so \"latest\" can be a moving target! However, I can give you a rundown of some of the most significant and ongoing trends and news in AI for healthcare as of my last update:\n",
      "\n",
      "**Key Areas of Advancement & News:**\n",
      "\n",
      "*   **Drug Discovery and Development:**\n",
      "    *   **Accelerated R&D:** AI is dramatically speeding up the identification of potential drug candidates, predicting their efficacy, and optimizing clinical trial design. Companies are using AI to analyze vast biological datasets to find novel targets and design molecules.\n",
      "    *   **Personalized Medicine:** AI is crucial for developing drugs tailored to an individual's genetic makeup and disease profile. This is leading to more effective treatments with fewer side effects.\n",
      "    *   **Recent News:** Many pharmaceutical giants are announcing new partnerships with AI drug discovery firms, and significant funding rounds continue for AI-focused biotech startups.\n",
      "\n",
      "*   **Medical Imaging and Diagnostics:**\n",
      "    *   **Enhanced Accuracy and Speed:** AI algorithms are becoming increasingly adept at analyzing medical images (X-rays, CT scans, MRIs, pathology slides) to detect diseases like cancer, diabetic retinopathy, and cardiovascular conditions with remarkable accuracy, sometimes even surpassing human radiologists.\n",
      "    *   **Early Detection:** AI's ability to spot subtle patterns can lead to earlier diagnoses, improving patient outcomes.\n",
      "    *   **News:** Regulatory approvals for AI-powered diagnostic tools are becoming more common. Many hospitals are integrating these tools into their workflows.\n",
      "\n",
      "*   **Personalized Treatment Plans and Patient Monitoring:**\n",
      "    *   **Predictive Analytics:** AI can predict a patient's risk of developing certain conditions or experiencing adverse events, allowing for proactive interventions.\n",
      "    *   **Remote Patient Monitoring:** Wearable devices and AI-powered platforms enable continuous monitoring of vital signs and patient behavior, alerting healthcare providers to potential issues before they become critical.\n",
      "    *   **Treatment Optimization:** AI can analyze a patient's response to different treatments and recommend adjustments for optimal outcomes.\n",
      "\n",
      "*   **Administrative Efficiency and Workflow Optimization:**\n",
      "    *   **Reducing Burnout:** AI is being used to automate tedious administrative tasks like scheduling, billing, and documentation, freeing up clinicians' time to focus on patient care.\n",
      "    *   **Streamlining Operations:** AI can optimize hospital resource allocation, manage patient flow, and improve supply chain management.\n",
      "\n",
      "*   **AI-Powered Chatbots and Virtual Assistants:**\n",
      "    *   **Patient Engagement:** These tools can answer common patient questions, provide appointment reminders, and offer basic health information, improving access and engagement.\n",
      "    *   **Clinical Support:** Some AI assistants can help clinicians by summarizing patient records or suggesting relevant medical literature.\n",
      "\n",
      "**Emerging Trends and Challenges:**\n",
      "\n",
      "*   **Generative AI in Healthcare:** Large Language Models (LLMs) are showing promise in areas like clinical note generation, medical report summarization, and even aiding in medical education. However, concerns about accuracy, bias, and privacy are paramount.\n",
      "*   **Explainable AI (XAI):** As AI systems become more complex, there's a growing demand for transparency. Clinicians need to understand *why* an AI makes a particular recommendation to trust and adopt it.\n",
      "*   **Data Privacy and Security:** With vast amounts of sensitive patient data being used, ensuring robust data privacy and cybersecurity is a critical ongoing challenge.\n",
      "*   **Regulatory Hurdles:** Navigating the complex regulatory landscape for AI in healthcare (e.g., FDA approvals) is a significant factor in the speed of adoption.\n",
      "*   **Ethical Considerations:** Addressing issues of bias in AI algorithms, ensuring equitable access to AI-powered healthcare, and defining accountability for AI-driven decisions are crucial.\n",
      "\n",
      "**Where to Find the Latest News:**\n",
      "\n",
      "To stay truly up-to-the-minute, I'd recommend checking out:\n",
      "\n",
      "*   **Reputable Healthcare and Technology News Outlets:** Sites like Fierce Healthcare, STAT News, MobiHealthNews, Healthcare IT News, and tech publications like TechCrunch or Axios.\n",
      "*   **Medical Journals:** Major journals often publish research on AI applications in healthcare.\n",
      "*   **Industry Conferences:** Major healthcare and AI conferences are where many new developments are announced.\n",
      "\n",
      "AI in healthcare is not just a futuristic concept anymore; it's actively being implemented and researched across numerous domains, with the potential to fundamentally transform how we prevent, diagnose, and treat illness.\n",
      "\n",
      " ### SESSION: compaction_demo\n",
      "\n",
      " User > Are there any new developments in drug discovery?\n",
      "gemini-2.5-flash-lite >  Yes, absolutely! Drug discovery is one of the areas where AI is having a particularly **profound and rapid impact**. Here are some of the key new developments and trends in AI-powered drug discovery:\n",
      "\n",
      "**1. Generative AI for Novel Molecule Design:**\n",
      "*   **De Novo Design:** Instead of screening existing libraries of compounds, generative AI models (like GANs or variational autoencoders) can *design entirely new molecules* from scratch that are optimized for specific properties (e.g., binding affinity to a target, solubility, low toxicity).\n",
      "*   **Targeted Design:** These models can be trained to generate molecules that fit precisely into the binding pockets of disease-causing proteins.\n",
      "*   **News:** Many AI drug discovery companies are reporting success in designing novel candidate molecules that are now entering preclinical or even early clinical trials.\n",
      "\n",
      "**2. Enhanced Target Identification and Validation:**\n",
      "*   **Multi-omics Integration:** AI can analyze vast datasets from genomics, proteomics, transcriptomics, and metabolomics to identify novel biological targets associated with diseases that might have been missed by traditional methods.\n",
      "*   **Network Biology:** AI helps in understanding complex biological pathways and identifying key nodes (targets) within these networks that can be modulated to treat a disease.\n",
      "*   **Predicting Drugability:** AI models can assess whether a newly identified target is \"drugable\" – meaning it's likely that a small molecule or biologic can effectively interact with it.\n",
      "\n",
      "**3. Accelerating Preclinical Research:**\n",
      "*   **Predicting ADMET Properties:** AI is getting much better at predicting Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties of drug candidates early in the process. This helps de-risk candidates and reduce costly failures in later stages.\n",
      "*   **In Silico Screening and Efficacy Prediction:** AI can simulate how a drug candidate might behave in biological systems, reducing the need for some initial wet-lab experiments.\n",
      "*   **Designing Better Preclinical Models:** AI can help select the most appropriate animal models or in vitro systems for testing drug candidates.\n",
      "\n",
      "**4. Optimizing Clinical Trial Design and Patient Selection:**\n",
      "*   **Predicting Trial Success:** AI can analyze historical clinical trial data and patient characteristics to predict the likelihood of success for a new trial.\n",
      "*   **Identifying Patient Subgroups:** AI can help identify specific patient populations that are most likely to respond to a particular drug, leading to more targeted and efficient clinical trials.\n",
      "*   **Synthetic Control Arms:** In some cases, AI can help generate \"synthetic\" control arms using real-world data, potentially reducing the need for large placebo groups.\n",
      "\n",
      "**5. AI for Biologics and Antibody Discovery:**\n",
      "*   **Antibody Engineering:** AI is used to design antibodies with improved binding affinity, stability, and reduced immunogenicity.\n",
      "*   **Predicting Epitopes:** AI can help predict which parts of a target protein are most likely to be recognized by an antibody.\n",
      "\n",
      "**Key Companies and Investments:**\n",
      "\n",
      "The field is seeing significant investment and activity from both established pharmaceutical giants and specialized AI drug discovery startups. Companies like **Recursion Pharmaceuticals, Exscientia, BenevolentAI, Atomwise, Insitro, and Schrödinger** are at the forefront, often partnering with larger pharma companies.\n",
      "\n",
      "**Challenges Remain:**\n",
      "\n",
      "Despite the incredible progress, challenges persist:\n",
      "*   **Data Quality and Accessibility:** High-quality, well-annotated biological data is essential for training effective AI models.\n",
      "*   **Validation:** Rigorous experimental validation is still crucial to confirm AI-generated hypotheses.\n",
      "*   **Interpretability:** Understanding *why* an AI model makes a certain prediction can still be difficult, especially for complex models.\n",
      "*   **Regulatory Acceptance:** Evolving regulatory frameworks are still adapting to AI-driven drug discovery.\n",
      "\n",
      "In summary, AI is not just an incremental improvement in drug discovery; it's a paradigm shift, enabling researchers to explore chemical and biological space in ways that were previously impossible, leading to faster, more efficient, and potentially more successful development of new medicines.\n",
      "\n",
      " ### SESSION: compaction_demo\n",
      "\n",
      " User > Tell me more about the second development you found.\n",
      "gemini-2.5-flash-lite >  You're asking about the second development I mentioned: **Enhanced Target Identification and Validation**. This is a crucial area because finding the right target is the foundational step in developing any new drug. If you hit the wrong target, or a target that isn't actually involved in the disease process, your drug won't work, no matter how well-designed it is.\n",
      "\n",
      "Here's a deeper dive into how AI is revolutionizing target identification and validation:\n",
      "\n",
      "**1. Multi-omics Integration: Unraveling Biological Complexity**\n",
      "\n",
      "*   **What it is:** \"Omics\" refers to different types of large-scale biological data:\n",
      "    *   **Genomics:** Studies the complete set of genes (DNA).\n",
      "    *   **Transcriptomics:** Studies the RNA molecules produced by genes, indicating gene activity.\n",
      "    *   **Proteomics:** Studies the complete set of proteins, which are the workhorses of the cell.\n",
      "    *   **Metabolomics:** Studies the small molecules (metabolites) involved in cellular processes.\n",
      "    *   **Epigenomics:** Studies modifications to DNA that affect gene activity without changing the DNA sequence itself.\n",
      "*   **The Challenge:** Each of these datasets provides a piece of the puzzle. Individually, they can be informative, but they often don't tell the whole story. Diseases are rarely caused by a single genetic mutation; they are complex dysregulations involving multiple genes, proteins, and metabolic pathways.\n",
      "*   **AI's Role:** AI, particularly machine learning, excels at finding patterns and correlations within massive, heterogeneous datasets.\n",
      "    *   **Pattern Recognition:** AI algorithms can sift through millions of data points across genomics, transcriptomics, and proteomics to identify patterns that are consistently altered in diseased cells or tissues compared to healthy ones.\n",
      "    *   **Identifying Causal Links:** By analyzing these complex interactions, AI can help infer which alterations are most likely driving the disease (potential targets) and which are just byproducts.\n",
      "    *   **Connecting the Dots:** AI can help bridge the gap between different omics layers. For example, it might find that a specific genetic variation (genomics) leads to increased production of a particular protein (proteomics) which then disrupts a metabolic pathway (metabolomics).\n",
      "\n",
      "**2. Network Biology: Mapping Disease Pathways**\n",
      "\n",
      "*   **What it is:** Our cells function as intricate networks, with proteins interacting with each other, genes regulating protein production, and metabolites influencing these processes. Network biology aims to map these relationships.\n",
      "*   **The Challenge:** These networks are incredibly complex and dynamic. Understanding how a disease disrupts these networks and identifying key \"bottlenecks\" or \"hubs\" that, if targeted, could correct the disruption is a monumental task for human analysis alone.\n",
      "*   **AI's Role:**\n",
      "    *   **Building Comprehensive Networks:** AI can integrate vast amounts of interaction data (protein-protein interactions, gene regulatory networks, metabolic pathways) to construct detailed biological networks.\n",
      "    *   **Identifying Critical Nodes:** By analyzing the structure and dynamics of these networks, AI can pinpoint proteins or genes that are central to disease progression. Targeting these \"central\" players can have a more profound therapeutic effect.\n",
      "    *   **Predicting Off-Target Effects:** By understanding the network, AI can also help predict potential \"off-target\" effects of a drug – where hitting one target might inadvertently disrupt other, unrelated pathways, leading to side effects.\n",
      "\n",
      "**3. Predicting \"Drugability\"**\n",
      "\n",
      "*   **What it is:** A target might be biologically relevant to a disease, but it's useless for drug development if we can't actually develop a molecule that can bind to it effectively and modulate its activity. This is the concept of \"drugability.\"\n",
      "*   **The Challenge:** Predicting whether a protein has a suitable binding site for a small molecule or antibody, and whether modulating it will have the desired therapeutic outcome without causing harm, is difficult.\n",
      "*   **AI's Role:**\n",
      "    *   **Structural Analysis:** AI models can analyze the 3D structure of proteins (often predicted by AI itself, like AlphaFold) to identify potential binding pockets.\n",
      "    *   **Predicting Modulatory Effects:** AI can learn from existing drugs and their targets to predict whether modulating a particular target is likely to be beneficial or detrimental.\n",
      "    *   **Prioritization:** This helps researchers prioritize which biological targets are most promising for further drug development efforts, saving time and resources.\n",
      "\n",
      "**In essence, AI helps researchers move from a fragmented view of disease to a holistic, interconnected understanding. By integrating diverse biological data and analyzing complex biological networks, AI is enabling the identification of novel, more promising drug targets that were previously hidden or too complex to uncover.**\n",
      "\n",
      "This enhanced target identification and validation is a critical upstream step that directly feeds into the downstream AI-powered drug design and development processes we discussed earlier.\n",
      "\n",
      " ### SESSION: compaction_demo\n",
      "\n",
      " User > Who are the main companies involved in that?\n",
      "gemini-2.5-flash-lite >  When we talk about companies involved in **enhanced target identification and validation using AI**, it's a broad category because this capability is often integrated into a larger AI drug discovery platform. However, there are companies that either specialize in this aspect or have it as a core strength within their broader offerings.\n",
      "\n",
      "Here are some of the main types of companies and specific examples, keeping in mind that this field is constantly evolving with new players emerging and existing ones expanding:\n",
      "\n",
      "**1. AI-Native Drug Discovery Companies (Platform Approach)**\n",
      "\n",
      "These companies build comprehensive AI platforms that cover multiple stages of drug discovery, from target ID to preclinical candidate selection. Target ID is a fundamental part of their engine.\n",
      "\n",
      "*   **Recursion Pharmaceuticals:** They use AI to analyze vast amounts of cellular imagery (phenotypic screening) combined with omics data. They aim to understand cellular states and identify novel targets by observing how cells respond to various perturbations and potential drug compounds. Their platform is designed to discover targets and treatments simultaneously.\n",
      "*   **BenevolentAI:** They have built a knowledge graph that integrates vast amounts of scientific literature, patents, and clinical trial data. Their AI algorithms mine this graph to uncover hidden relationships between genes, proteins, diseases, and drugs, thereby identifying novel targets and biomarkers.\n",
      "*   **Exscientia:** While known for their generative AI in molecule design, Exscientia also heavily focuses on target identification and validation as part of their end-to-end platform. They use AI to understand disease biology and select optimal targets for their AI-driven drug design process.\n",
      "*   **Insitro:** This company focuses on building a data-driven drug discovery machine. They generate high-quality, large-scale biological data (multi-omics) and use machine learning to derive novel insights and identify targets, particularly in areas like neurodegeneration and oncology.\n",
      "\n",
      "**2. Specialized AI & Data Analytics Companies with Pharma Focus**\n",
      "\n",
      "Some companies focus specifically on leveraging AI for biological insights, which directly contribute to target identification.\n",
      "\n",
      "*   **BioXcel Therapeutics:** They use AI to identify novel therapeutic applications for existing drugs and to discover new drug candidates. Their AI platform analyzes vast datasets, including genomic, proteomic, and clinical data, to identify novel targets and drug mechanisms.\n",
      "*   **Relay Therapeutics:** While focusing on protein motion and dynamics, their approach inherently involves understanding how targets function at a molecular level, which is crucial for validating their role in disease and identifying druggable sites.\n",
      "\n",
      "**3. Traditional Pharmaceutical Companies (Internal R&D & Partnerships)**\n",
      "\n",
      "Major pharmaceutical companies are increasingly investing heavily in building their own internal AI capabilities or partnering with AI drug discovery firms.\n",
      "\n",
      "*   **Pfizer, Novartis, AstraZeneca, Roche, Merck, etc.:** These giants are establishing dedicated AI/ML departments, acquiring AI companies, and forming strategic alliances to leverage AI for target identification, validation, and beyond. They have the deep biological expertise and the massive historical datasets that are invaluable for training AI models.\n",
      "*   **Examples of Partnerships:** You'll often see announcements of pharma companies partnering with companies like BenevolentAI, Exscientia, or Recursion to co-discover drugs, where target identification is a key initial phase.\n",
      "\n",
      "**4. Tech Giants with Healthcare Divisions**\n",
      "\n",
      "While not always directly *discovering* targets in the traditional sense, tech giants are developing foundational AI technologies and platforms that enable this work.\n",
      "\n",
      "*   **Google (Alphabet):** Through **Google Health** and its subsidiary **Isomorphic Labs** (focused on drug discovery), they are applying AI, including foundational models like AlphaFold, to predict protein structures and understand biological mechanisms, which is critical for target identification.\n",
      "*   **Microsoft:** Provides cloud computing infrastructure and AI tools that many biotech and pharma companies use to build their own AI drug discovery platforms. They also engage in partnerships for healthcare AI.\n",
      "\n",
      "**Key Capabilities these Companies Leverage:**\n",
      "\n",
      "*   **Machine Learning Algorithms:** For pattern recognition, classification, and prediction.\n",
      "*   **Natural Language Processing (NLP):** To extract information from unstructured scientific literature.\n",
      "*   **Knowledge Graphs:** To represent and query complex relationships between biological entities.\n",
      "*   **High-Performance Computing (HPC) & Cloud Infrastructure:** To handle massive datasets and complex computations.\n",
      "*   **Data Integration Expertise:** To combine diverse data types (genomics, proteomics, imaging, clinical records, literature).\n",
      "\n",
      "It's important to note that the lines between these categories are often blurred. Many AI drug discovery companies are building end-to-end platforms, while traditional pharma companies are becoming increasingly AI-savvy. The collaboration between these entities is also a significant driver of progress in this area.\n"
     ]
    }
   ],
   "source": [
    "# Turn 1\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"What is the latest news about AI in healthcare?\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 2\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Are there any new developments in drug discovery?\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 3 - Compaction should trigger after this turn!\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Tell me more about the second development you found.\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 4\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Who are the main companies involved in that?\",\n",
    "    \"compaction_demo\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "1d342742",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "id='compaction_demo' app_name='research_app_compacting' user_id='default' state={} events=[Event(model_version=None, content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text='What is the latest news about AI in healthcare?'\n",
      "    ),\n",
      "  ],\n",
      "  role='user'\n",
      "), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-2bc2fb93-69b4-424c-b6b8-0b36270067d1', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='43efaa7c-9f8f-4d85-8291-63423d822aea', timestamp=1763508658.829886), Event(model_version=None, content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text=\"\"\"The field of AI in healthcare is rapidly evolving, so \"latest\" can be a moving target! However, I can give you a rundown of some of the most significant and ongoing trends and news in AI for healthcare as of my last update:\n",
      "\n",
      "**Key Areas of Advancement & News:**\n",
      "\n",
      "*   **Drug Discovery and Development:**\n",
      "    *   **Accelerated R&D:** AI is dramatically speeding up the identification of potential drug candidates, predicting their efficacy, and optimizing clinical trial design. Companies are using AI to analyze vast biological datasets to find novel targets and design molecules.\n",
      "    *   **Personalized Medicine:** AI is crucial for developing drugs tailored to an individual's genetic makeup and disease profile. This is leading to more effective treatments with fewer side effects.\n",
      "    *   **Recent News:** Many pharmaceutical giants are announcing new partnerships with AI drug discovery firms, and significant funding rounds continue for AI-focused biotech startups.\n",
      "\n",
      "*   **Medical Imaging and Diagnostics:**\n",
      "    *   **Enhanced Accuracy and Speed:** AI algorithms are becoming increasingly adept at analyzing medical images (X-rays, CT scans, MRIs, pathology slides) to detect diseases like cancer, diabetic retinopathy, and cardiovascular conditions with remarkable accuracy, sometimes even surpassing human radiologists.\n",
      "    *   **Early Detection:** AI's ability to spot subtle patterns can lead to earlier diagnoses, improving patient outcomes.\n",
      "    *   **News:** Regulatory approvals for AI-powered diagnostic tools are becoming more common. Many hospitals are integrating these tools into their workflows.\n",
      "\n",
      "*   **Personalized Treatment Plans and Patient Monitoring:**\n",
      "    *   **Predictive Analytics:** AI can predict a patient's risk of developing certain conditions or experiencing adverse events, allowing for proactive interventions.\n",
      "    *   **Remote Patient Monitoring:** Wearable devices and AI-powered platforms enable continuous monitoring of vital signs and patient behavior, alerting healthcare providers to potential issues before they become critical.\n",
      "    *   **Treatment Optimization:** AI can analyze a patient's response to different treatments and recommend adjustments for optimal outcomes.\n",
      "\n",
      "*   **Administrative Efficiency and Workflow Optimization:**\n",
      "    *   **Reducing Burnout:** AI is being used to automate tedious administrative tasks like scheduling, billing, and documentation, freeing up clinicians' time to focus on patient care.\n",
      "    *   **Streamlining Operations:** AI can optimize hospital resource allocation, manage patient flow, and improve supply chain management.\n",
      "\n",
      "*   **AI-Powered Chatbots and Virtual Assistants:**\n",
      "    *   **Patient Engagement:** These tools can answer common patient questions, provide appointment reminders, and offer basic health information, improving access and engagement.\n",
      "    *   **Clinical Support:** Some AI assistants can help clinicians by summarizing patient records or suggesting relevant medical literature.\n",
      "\n",
      "**Emerging Trends and Challenges:**\n",
      "\n",
      "*   **Generative AI in Healthcare:** Large Language Models (LLMs) are showing promise in areas like clinical note generation, medical report summarization, and even aiding in medical education. However, concerns about accuracy, bias, and privacy are paramount.\n",
      "*   **Explainable AI (XAI):** As AI systems become more complex, there's a growing demand for transparency. Clinicians need to understand *why* an AI makes a particular recommendation to trust and adopt it.\n",
      "*   **Data Privacy and Security:** With vast amounts of sensitive patient data being used, ensuring robust data privacy and cybersecurity is a critical ongoing challenge.\n",
      "*   **Regulatory Hurdles:** Navigating the complex regulatory landscape for AI in healthcare (e.g., FDA approvals) is a significant factor in the speed of adoption.\n",
      "*   **Ethical Considerations:** Addressing issues of bias in AI algorithms, ensuring equitable access to AI-powered healthcare, and defining accountability for AI-driven decisions are crucial.\n",
      "\n",
      "**Where to Find the Latest News:**\n",
      "\n",
      "To stay truly up-to-the-minute, I'd recommend checking out:\n",
      "\n",
      "*   **Reputable Healthcare and Technology News Outlets:** Sites like Fierce Healthcare, STAT News, MobiHealthNews, Healthcare IT News, and tech publications like TechCrunch or Axios.\n",
      "*   **Medical Journals:** Major journals often publish research on AI applications in healthcare.\n",
      "*   **Industry Conferences:** Major healthcare and AI conferences are where many new developments are announced.\n",
      "\n",
      "AI in healthcare is not just a futuristic concept anymore; it's actively being implemented and researched across numerous domains, with the potential to fundamentally transform how we prevent, diagnose, and treat illness.\"\"\"\n",
      "    ),\n",
      "  ],\n",
      "  role='model'\n",
      "), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
      "  candidates_token_count=914,\n",
      "  prompt_token_count=41,\n",
      "  prompt_tokens_details=[\n",
      "    ModalityTokenCount(\n",
      "      modality=<MediaModality.TEXT: 'TEXT'>,\n",
      "      token_count=41\n",
      "    ),\n",
      "  ],\n",
      "  total_token_count=955\n",
      "), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-2bc2fb93-69b4-424c-b6b8-0b36270067d1', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='160626b8-fa2a-43b1-8277-c224551fc9cf', timestamp=1763508658.83268), Event(model_version=None, content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text='Are there any new developments in drug discovery?'\n",
      "    ),\n",
      "  ],\n",
      "  role='user'\n",
      "), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-0e5743d4-351a-4552-a7d4-2adac8aabe0e', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='6b156046-f2ef-4d55-a73e-a0ee4d1713ef', timestamp=1763508662.503009), Event(model_version=None, content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text=\"\"\"Yes, absolutely! Drug discovery is one of the areas where AI is having a particularly **profound and rapid impact**. Here are some of the key new developments and trends in AI-powered drug discovery:\n",
      "\n",
      "**1. Generative AI for Novel Molecule Design:**\n",
      "*   **De Novo Design:** Instead of screening existing libraries of compounds, generative AI models (like GANs or variational autoencoders) can *design entirely new molecules* from scratch that are optimized for specific properties (e.g., binding affinity to a target, solubility, low toxicity).\n",
      "*   **Targeted Design:** These models can be trained to generate molecules that fit precisely into the binding pockets of disease-causing proteins.\n",
      "*   **News:** Many AI drug discovery companies are reporting success in designing novel candidate molecules that are now entering preclinical or even early clinical trials.\n",
      "\n",
      "**2. Enhanced Target Identification and Validation:**\n",
      "*   **Multi-omics Integration:** AI can analyze vast datasets from genomics, proteomics, transcriptomics, and metabolomics to identify novel biological targets associated with diseases that might have been missed by traditional methods.\n",
      "*   **Network Biology:** AI helps in understanding complex biological pathways and identifying key nodes (targets) within these networks that can be modulated to treat a disease.\n",
      "*   **Predicting Drugability:** AI models can assess whether a newly identified target is \"drugable\" – meaning it's likely that a small molecule or biologic can effectively interact with it.\n",
      "\n",
      "**3. Accelerating Preclinical Research:**\n",
      "*   **Predicting ADMET Properties:** AI is getting much better at predicting Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties of drug candidates early in the process. This helps de-risk candidates and reduce costly failures in later stages.\n",
      "*   **In Silico Screening and Efficacy Prediction:** AI can simulate how a drug candidate might behave in biological systems, reducing the need for some initial wet-lab experiments.\n",
      "*   **Designing Better Preclinical Models:** AI can help select the most appropriate animal models or in vitro systems for testing drug candidates.\n",
      "\n",
      "**4. Optimizing Clinical Trial Design and Patient Selection:**\n",
      "*   **Predicting Trial Success:** AI can analyze historical clinical trial data and patient characteristics to predict the likelihood of success for a new trial.\n",
      "*   **Identifying Patient Subgroups:** AI can help identify specific patient populations that are most likely to respond to a particular drug, leading to more targeted and efficient clinical trials.\n",
      "*   **Synthetic Control Arms:** In some cases, AI can help generate \"synthetic\" control arms using real-world data, potentially reducing the need for large placebo groups.\n",
      "\n",
      "**5. AI for Biologics and Antibody Discovery:**\n",
      "*   **Antibody Engineering:** AI is used to design antibodies with improved binding affinity, stability, and reduced immunogenicity.\n",
      "*   **Predicting Epitopes:** AI can help predict which parts of a target protein are most likely to be recognized by an antibody.\n",
      "\n",
      "**Key Companies and Investments:**\n",
      "\n",
      "The field is seeing significant investment and activity from both established pharmaceutical giants and specialized AI drug discovery startups. Companies like **Recursion Pharmaceuticals, Exscientia, BenevolentAI, Atomwise, Insitro, and Schrödinger** are at the forefront, often partnering with larger pharma companies.\n",
      "\n",
      "**Challenges Remain:**\n",
      "\n",
      "Despite the incredible progress, challenges persist:\n",
      "*   **Data Quality and Accessibility:** High-quality, well-annotated biological data is essential for training effective AI models.\n",
      "*   **Validation:** Rigorous experimental validation is still crucial to confirm AI-generated hypotheses.\n",
      "*   **Interpretability:** Understanding *why* an AI model makes a certain prediction can still be difficult, especially for complex models.\n",
      "*   **Regulatory Acceptance:** Evolving regulatory frameworks are still adapting to AI-driven drug discovery.\n",
      "\n",
      "In summary, AI is not just an incremental improvement in drug discovery; it's a paradigm shift, enabling researchers to explore chemical and biological space in ways that were previously impossible, leading to faster, more efficient, and potentially more successful development of new medicines.\"\"\"\n",
      "    ),\n",
      "  ],\n",
      "  role='model'\n",
      "), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
      "  candidates_token_count=838,\n",
      "  prompt_token_count=966,\n",
      "  prompt_tokens_details=[\n",
      "    ModalityTokenCount(\n",
      "      modality=<MediaModality.TEXT: 'TEXT'>,\n",
      "      token_count=966\n",
      "    ),\n",
      "  ],\n",
      "  total_token_count=1804\n",
      "), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-0e5743d4-351a-4552-a7d4-2adac8aabe0e', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='befc8fd5-b5ff-4951-b246-5a813d49a59b', timestamp=1763508662.504779), Event(model_version=None, content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text='Tell me more about the second development you found.'\n",
      "    ),\n",
      "  ],\n",
      "  role='user'\n",
      "), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-84af406b-d63e-4aee-88e2-3c2bea06b0b6', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='3ae6b0d9-4f40-4c20-b890-44dfcccf5eb8', timestamp=1763508666.787836), Event(model_version=None, content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text=\"\"\"You're asking about the second development I mentioned: **Enhanced Target Identification and Validation**. This is a crucial area because finding the right target is the foundational step in developing any new drug. If you hit the wrong target, or a target that isn't actually involved in the disease process, your drug won't work, no matter how well-designed it is.\n",
      "\n",
      "Here's a deeper dive into how AI is revolutionizing target identification and validation:\n",
      "\n",
      "**1. Multi-omics Integration: Unraveling Biological Complexity**\n",
      "\n",
      "*   **What it is:** \"Omics\" refers to different types of large-scale biological data:\n",
      "    *   **Genomics:** Studies the complete set of genes (DNA).\n",
      "    *   **Transcriptomics:** Studies the RNA molecules produced by genes, indicating gene activity.\n",
      "    *   **Proteomics:** Studies the complete set of proteins, which are the workhorses of the cell.\n",
      "    *   **Metabolomics:** Studies the small molecules (metabolites) involved in cellular processes.\n",
      "    *   **Epigenomics:** Studies modifications to DNA that affect gene activity without changing the DNA sequence itself.\n",
      "*   **The Challenge:** Each of these datasets provides a piece of the puzzle. Individually, they can be informative, but they often don't tell the whole story. Diseases are rarely caused by a single genetic mutation; they are complex dysregulations involving multiple genes, proteins, and metabolic pathways.\n",
      "*   **AI's Role:** AI, particularly machine learning, excels at finding patterns and correlations within massive, heterogeneous datasets.\n",
      "    *   **Pattern Recognition:** AI algorithms can sift through millions of data points across genomics, transcriptomics, and proteomics to identify patterns that are consistently altered in diseased cells or tissues compared to healthy ones.\n",
      "    *   **Identifying Causal Links:** By analyzing these complex interactions, AI can help infer which alterations are most likely driving the disease (potential targets) and which are just byproducts.\n",
      "    *   **Connecting the Dots:** AI can help bridge the gap between different omics layers. For example, it might find that a specific genetic variation (genomics) leads to increased production of a particular protein (proteomics) which then disrupts a metabolic pathway (metabolomics).\n",
      "\n",
      "**2. Network Biology: Mapping Disease Pathways**\n",
      "\n",
      "*   **What it is:** Our cells function as intricate networks, with proteins interacting with each other, genes regulating protein production, and metabolites influencing these processes. Network biology aims to map these relationships.\n",
      "*   **The Challenge:** These networks are incredibly complex and dynamic. Understanding how a disease disrupts these networks and identifying key \"bottlenecks\" or \"hubs\" that, if targeted, could correct the disruption is a monumental task for human analysis alone.\n",
      "*   **AI's Role:**\n",
      "    *   **Building Comprehensive Networks:** AI can integrate vast amounts of interaction data (protein-protein interactions, gene regulatory networks, metabolic pathways) to construct detailed biological networks.\n",
      "    *   **Identifying Critical Nodes:** By analyzing the structure and dynamics of these networks, AI can pinpoint proteins or genes that are central to disease progression. Targeting these \"central\" players can have a more profound therapeutic effect.\n",
      "    *   **Predicting Off-Target Effects:** By understanding the network, AI can also help predict potential \"off-target\" effects of a drug – where hitting one target might inadvertently disrupt other, unrelated pathways, leading to side effects.\n",
      "\n",
      "**3. Predicting \"Drugability\"**\n",
      "\n",
      "*   **What it is:** A target might be biologically relevant to a disease, but it's useless for drug development if we can't actually develop a molecule that can bind to it effectively and modulate its activity. This is the concept of \"drugability.\"\n",
      "*   **The Challenge:** Predicting whether a protein has a suitable binding site for a small molecule or antibody, and whether modulating it will have the desired therapeutic outcome without causing harm, is difficult.\n",
      "*   **AI's Role:**\n",
      "    *   **Structural Analysis:** AI models can analyze the 3D structure of proteins (often predicted by AI itself, like AlphaFold) to identify potential binding pockets.\n",
      "    *   **Predicting Modulatory Effects:** AI can learn from existing drugs and their targets to predict whether modulating a particular target is likely to be beneficial or detrimental.\n",
      "    *   **Prioritization:** This helps researchers prioritize which biological targets are most promising for further drug development efforts, saving time and resources.\n",
      "\n",
      "**In essence, AI helps researchers move from a fragmented view of disease to a holistic, interconnected understanding. By integrating diverse biological data and analyzing complex biological networks, AI is enabling the identification of novel, more promising drug targets that were previously hidden or too complex to uncover.**\n",
      "\n",
      "This enhanced target identification and validation is a critical upstream step that directly feeds into the downstream AI-powered drug design and development processes we discussed earlier.\"\"\"\n",
      "    ),\n",
      "  ],\n",
      "  role='model'\n",
      "), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
      "  candidates_token_count=1014,\n",
      "  prompt_token_count=1816,\n",
      "  prompt_tokens_details=[\n",
      "    ModalityTokenCount(\n",
      "      modality=<MediaModality.TEXT: 'TEXT'>,\n",
      "      token_count=1816\n",
      "    ),\n",
      "  ],\n",
      "  total_token_count=2830\n",
      "), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-84af406b-d63e-4aee-88e2-3c2bea06b0b6', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='c29351fd-e5d2-4e70-a315-c6e727639ea7', timestamp=1763508666.789436), Event(model_version=None, content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text='Who are the main companies involved in that?'\n",
      "    ),\n",
      "  ],\n",
      "  role='user'\n",
      "), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-3f61a5f5-5df0-4ba0-b4e5-fb1f0c7e8c4e', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='949bf917-1809-43b1-b106-ecc99d1e5d1b', timestamp=1763508670.97266), Event(model_version=None, content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text=\"\"\"When we talk about companies involved in **enhanced target identification and validation using AI**, it's a broad category because this capability is often integrated into a larger AI drug discovery platform. However, there are companies that either specialize in this aspect or have it as a core strength within their broader offerings.\n",
      "\n",
      "Here are some of the main types of companies and specific examples, keeping in mind that this field is constantly evolving with new players emerging and existing ones expanding:\n",
      "\n",
      "**1. AI-Native Drug Discovery Companies (Platform Approach)**\n",
      "\n",
      "These companies build comprehensive AI platforms that cover multiple stages of drug discovery, from target ID to preclinical candidate selection. Target ID is a fundamental part of their engine.\n",
      "\n",
      "*   **Recursion Pharmaceuticals:** They use AI to analyze vast amounts of cellular imagery (phenotypic screening) combined with omics data. They aim to understand cellular states and identify novel targets by observing how cells respond to various perturbations and potential drug compounds. Their platform is designed to discover targets and treatments simultaneously.\n",
      "*   **BenevolentAI:** They have built a knowledge graph that integrates vast amounts of scientific literature, patents, and clinical trial data. Their AI algorithms mine this graph to uncover hidden relationships between genes, proteins, diseases, and drugs, thereby identifying novel targets and biomarkers.\n",
      "*   **Exscientia:** While known for their generative AI in molecule design, Exscientia also heavily focuses on target identification and validation as part of their end-to-end platform. They use AI to understand disease biology and select optimal targets for their AI-driven drug design process.\n",
      "*   **Insitro:** This company focuses on building a data-driven drug discovery machine. They generate high-quality, large-scale biological data (multi-omics) and use machine learning to derive novel insights and identify targets, particularly in areas like neurodegeneration and oncology.\n",
      "\n",
      "**2. Specialized AI & Data Analytics Companies with Pharma Focus**\n",
      "\n",
      "Some companies focus specifically on leveraging AI for biological insights, which directly contribute to target identification.\n",
      "\n",
      "*   **BioXcel Therapeutics:** They use AI to identify novel therapeutic applications for existing drugs and to discover new drug candidates. Their AI platform analyzes vast datasets, including genomic, proteomic, and clinical data, to identify novel targets and drug mechanisms.\n",
      "*   **Relay Therapeutics:** While focusing on protein motion and dynamics, their approach inherently involves understanding how targets function at a molecular level, which is crucial for validating their role in disease and identifying druggable sites.\n",
      "\n",
      "**3. Traditional Pharmaceutical Companies (Internal R&D & Partnerships)**\n",
      "\n",
      "Major pharmaceutical companies are increasingly investing heavily in building their own internal AI capabilities or partnering with AI drug discovery firms.\n",
      "\n",
      "*   **Pfizer, Novartis, AstraZeneca, Roche, Merck, etc.:** These giants are establishing dedicated AI/ML departments, acquiring AI companies, and forming strategic alliances to leverage AI for target identification, validation, and beyond. They have the deep biological expertise and the massive historical datasets that are invaluable for training AI models.\n",
      "*   **Examples of Partnerships:** You'll often see announcements of pharma companies partnering with companies like BenevolentAI, Exscientia, or Recursion to co-discover drugs, where target identification is a key initial phase.\n",
      "\n",
      "**4. Tech Giants with Healthcare Divisions**\n",
      "\n",
      "While not always directly *discovering* targets in the traditional sense, tech giants are developing foundational AI technologies and platforms that enable this work.\n",
      "\n",
      "*   **Google (Alphabet):** Through **Google Health** and its subsidiary **Isomorphic Labs** (focused on drug discovery), they are applying AI, including foundational models like AlphaFold, to predict protein structures and understand biological mechanisms, which is critical for target identification.\n",
      "*   **Microsoft:** Provides cloud computing infrastructure and AI tools that many biotech and pharma companies use to build their own AI drug discovery platforms. They also engage in partnerships for healthcare AI.\n",
      "\n",
      "**Key Capabilities these Companies Leverage:**\n",
      "\n",
      "*   **Machine Learning Algorithms:** For pattern recognition, classification, and prediction.\n",
      "*   **Natural Language Processing (NLP):** To extract information from unstructured scientific literature.\n",
      "*   **Knowledge Graphs:** To represent and query complex relationships between biological entities.\n",
      "*   **High-Performance Computing (HPC) & Cloud Infrastructure:** To handle massive datasets and complex computations.\n",
      "*   **Data Integration Expertise:** To combine diverse data types (genomics, proteomics, imaging, clinical records, literature).\n",
      "\n",
      "It's important to note that the lines between these categories are often blurred. Many AI drug discovery companies are building end-to-end platforms, while traditional pharma companies are becoming increasingly AI-savvy. The collaboration between these entities is also a significant driver of progress in this area.\"\"\"\n",
      "    ),\n",
      "  ],\n",
      "  role='model'\n",
      "), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
      "  candidates_token_count=959,\n",
      "  prompt_token_count=2841,\n",
      "  prompt_tokens_details=[\n",
      "    ModalityTokenCount(\n",
      "      modality=<MediaModality.TEXT: 'TEXT'>,\n",
      "      token_count=2841\n",
      "    ),\n",
      "  ],\n",
      "  total_token_count=3800\n",
      "), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-3f61a5f5-5df0-4ba0-b4e5-fb1f0c7e8c4e', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='1341cb05-d473-4a02-b60f-0dd412348cfd', timestamp=1763508670.97898), Event(model_version=None, content=None, grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='87acb603-a521-407e-bbae-4887435cdb1e', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763508658.829886, 'end_timestamp': 1763508666.789436, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user is asking for a summary of the conversation, focusing on key information, decisions, and unresolved questions.\\n\\nThe conversation began with the user inquiring about the latest news in AI in healthcare. The AI agent provided a comprehensive overview of key areas of advancement, including drug discovery, medical imaging, personalized treatment, administrative efficiency, and AI-powered assistants. It also highlighted emerging trends like generative AI, explainable AI, and challenges such as data privacy, regulatory hurdles, and ethical considerations. The AI agent then directed the user to reputable sources for up-to-the-minute news.\\n\\nThe user then specifically asked for more information on new developments in drug discovery. The AI agent elaborated on five key areas: generative AI for molecule design, enhanced target identification/validation, accelerating preclinical research, optimizing clinical trials, and AI for biologics/antibody discovery. It also mentioned prominent companies in the field and reiterated remaining challenges.\\n\\nThe user then requested further details on the second development mentioned: \"Enhanced Target Identification and Validation.\" The AI agent provided an in-depth explanation of this area, focusing on:\\n\\n*   **Multi-omics Integration:** How AI analyzes diverse biological data (genomics, transcriptomics, proteomics, metabolomics, epigenomics) to identify patterns and causal links in disease.\\n*   **Network Biology:** How AI maps complex biological networks to identify critical disease-driving nodes and predict off-target effects.\\n*   **Predicting \"Drugability\":** How AI assesses the potential for a target to be modulated by a drug, considering structural analysis and predicting therapeutic outcomes.\\n\\nThe AI agent emphasized that enhanced target identification and validation is a foundational upstream step that improves downstream drug discovery processes.\\n\\n**Key Information & Decisions:**\\n\\n*   **AI is transforming healthcare across multiple domains, with significant impact on drug discovery.**\\n*   **Generative AI is enabling the design of novel drug molecules.**\\n*   **AI is crucial for identifying and validating new drug targets by analyzing complex biological data and networks.**\\n*   **Key companies and investments are driving innovation in AI-powered drug discovery.**\\n*   **Data quality, validation, interpretability, and regulatory acceptance remain challenges.**\\n\\n**Unresolved Questions/Tasks:**\\n\\n*   None. The conversation has been an informative exchange of information, with the user driving the depth of discussion by asking for elaboration on specific points. The AI has provided detailed explanations in response to each query.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='9df22d0f-fa69-4a42-8f4b-d2033bcfc58c', timestamp=1763508673.062786), Event(model_version=None, content=None, grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='f8817a69-1b44-4e88-8f17-5dfed97f02f0', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763508658.829886, 'end_timestamp': 1763508670.97898, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': \"The conversation began with a user asking for the latest news on AI in healthcare. The AI agent provided a comprehensive overview of key advancements and ongoing trends, including:\\n\\n*   **Drug Discovery and Development:** AI is accelerating R&D, enabling personalized medicine, and driving partnerships between pharma and AI firms.\\n*   **Medical Imaging and Diagnostics:** AI is enhancing accuracy and speed in detecting diseases, with increasing regulatory approvals.\\n*   **Personalized Treatment Plans and Patient Monitoring:** AI is used for predictive analytics, remote monitoring, and treatment optimization.\\n*   **Administrative Efficiency:** AI is automating tasks to reduce clinician burnout and streamline operations.\\n*   **AI-Powered Chatbots and Virtual Assistants:** These tools are improving patient engagement and clinical support.\\n\\nEmerging trends and challenges were also highlighted, such as generative AI, explainable AI (XAI), data privacy, regulatory hurdles, and ethical considerations. The AI agent recommended specific news sources for staying up-to-date.\\n\\nThe user then asked for more details on new developments in drug discovery. The AI agent elaborated on this, focusing on:\\n\\n*   **Generative AI for Novel Molecule Design:** AI can create new molecules optimized for specific properties.\\n*   **Enhanced Target Identification and Validation:** AI uses multi-omics data and network biology to find and validate crucial disease targets.\\n*   **Accelerating Preclinical Research:** AI predicts drug properties (ADMET) and efficacy, and optimizes preclinical models.\\n*   **Optimizing Clinical Trial Design:** AI predicts trial success and identifies patient subgroups.\\n*   **AI for Biologics and Antibody Discovery:** AI is used for antibody engineering and epitope prediction.\\n\\nThe agent also mentioned key companies in this space and persistent challenges like data quality, validation, interpretability, and regulatory acceptance.\\n\\nThe user's subsequent query focused on the companies involved in **Enhanced Target Identification and Validation using AI**. The AI agent identified several categories of companies:\\n\\n*   **AI-Native Drug Discovery Companies (Platform Approach):** Companies like Recursion Pharmaceuticals, BenevolentAI, Exscientia, and Insitro offer comprehensive AI platforms where target ID is a core component.\\n*   **Specialized AI & Data Analytics Companies with Pharma Focus:** Companies like BioXcel Therapeutics and Relay Therapeutics leverage AI for biological insights crucial for target identification.\\n*   **Traditional Pharmaceutical Companies:** Major pharma giants (Pfizer, Novartis, etc.) are building internal AI capabilities and forming partnerships.\\n*   **Tech Giants with Healthcare Divisions:** Companies like Google (Isomorphic Labs) and Microsoft are developing foundational AI technologies and platforms that enable target identification work.\\n\\nThe agent emphasized that many companies offer end-to-end solutions and that collaboration is a significant driver of progress.\\n\\n**Key Information and Decisions Made:**\\n\\n*   The user received a broad overview of AI in healthcare and then drilled down into AI's impact on drug discovery, specifically target identification and validation.\\n*   The AI agent provided detailed explanations of complex concepts like multi-omics and network biology.\\n*   Specific company names and their roles in the field were identified.\\n\\n**Unresolved Questions or Tasks:**\\n\\n*   None. The conversation has been a request for information, and the AI agent has provided comprehensive answers to each user query.\", 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='c93d60de-a3f2-4394-b217-4f1bdcdeb7d1', timestamp=1763508678.759773)] last_update_time=1763508658.0\n"
     ]
    }
   ],
   "source": [
    "final_session = await session_service.get_session(\n",
    "    app_name=research_runner_compacting.app_name,\n",
    "    user_id=USER_ID,\n",
    "    session_id=\"compaction_demo\",\n",
    ")\n",
    "print(final_session)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "29bccd92",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "model_version=None content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text='What is the latest news about AI in healthcare?'\n",
      "    ),\n",
      "  ],\n",
      "  role='user'\n",
      ") grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e-2bc2fb93-69b4-424c-b6b8-0b36270067d1' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='43efaa7c-9f8f-4d85-8291-63423d822aea' timestamp=1763508658.829886\n",
      "model_version=None content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text=\"\"\"The field of AI in healthcare is rapidly evolving, so \"latest\" can be a moving target! However, I can give you a rundown of some of the most significant and ongoing trends and news in AI for healthcare as of my last update:\n",
      "\n",
      "**Key Areas of Advancement & News:**\n",
      "\n",
      "*   **Drug Discovery and Development:**\n",
      "    *   **Accelerated R&D:** AI is dramatically speeding up the identification of potential drug candidates, predicting their efficacy, and optimizing clinical trial design. Companies are using AI to analyze vast biological datasets to find novel targets and design molecules.\n",
      "    *   **Personalized Medicine:** AI is crucial for developing drugs tailored to an individual's genetic makeup and disease profile. This is leading to more effective treatments with fewer side effects.\n",
      "    *   **Recent News:** Many pharmaceutical giants are announcing new partnerships with AI drug discovery firms, and significant funding rounds continue for AI-focused biotech startups.\n",
      "\n",
      "*   **Medical Imaging and Diagnostics:**\n",
      "    *   **Enhanced Accuracy and Speed:** AI algorithms are becoming increasingly adept at analyzing medical images (X-rays, CT scans, MRIs, pathology slides) to detect diseases like cancer, diabetic retinopathy, and cardiovascular conditions with remarkable accuracy, sometimes even surpassing human radiologists.\n",
      "    *   **Early Detection:** AI's ability to spot subtle patterns can lead to earlier diagnoses, improving patient outcomes.\n",
      "    *   **News:** Regulatory approvals for AI-powered diagnostic tools are becoming more common. Many hospitals are integrating these tools into their workflows.\n",
      "\n",
      "*   **Personalized Treatment Plans and Patient Monitoring:**\n",
      "    *   **Predictive Analytics:** AI can predict a patient's risk of developing certain conditions or experiencing adverse events, allowing for proactive interventions.\n",
      "    *   **Remote Patient Monitoring:** Wearable devices and AI-powered platforms enable continuous monitoring of vital signs and patient behavior, alerting healthcare providers to potential issues before they become critical.\n",
      "    *   **Treatment Optimization:** AI can analyze a patient's response to different treatments and recommend adjustments for optimal outcomes.\n",
      "\n",
      "*   **Administrative Efficiency and Workflow Optimization:**\n",
      "    *   **Reducing Burnout:** AI is being used to automate tedious administrative tasks like scheduling, billing, and documentation, freeing up clinicians' time to focus on patient care.\n",
      "    *   **Streamlining Operations:** AI can optimize hospital resource allocation, manage patient flow, and improve supply chain management.\n",
      "\n",
      "*   **AI-Powered Chatbots and Virtual Assistants:**\n",
      "    *   **Patient Engagement:** These tools can answer common patient questions, provide appointment reminders, and offer basic health information, improving access and engagement.\n",
      "    *   **Clinical Support:** Some AI assistants can help clinicians by summarizing patient records or suggesting relevant medical literature.\n",
      "\n",
      "**Emerging Trends and Challenges:**\n",
      "\n",
      "*   **Generative AI in Healthcare:** Large Language Models (LLMs) are showing promise in areas like clinical note generation, medical report summarization, and even aiding in medical education. However, concerns about accuracy, bias, and privacy are paramount.\n",
      "*   **Explainable AI (XAI):** As AI systems become more complex, there's a growing demand for transparency. Clinicians need to understand *why* an AI makes a particular recommendation to trust and adopt it.\n",
      "*   **Data Privacy and Security:** With vast amounts of sensitive patient data being used, ensuring robust data privacy and cybersecurity is a critical ongoing challenge.\n",
      "*   **Regulatory Hurdles:** Navigating the complex regulatory landscape for AI in healthcare (e.g., FDA approvals) is a significant factor in the speed of adoption.\n",
      "*   **Ethical Considerations:** Addressing issues of bias in AI algorithms, ensuring equitable access to AI-powered healthcare, and defining accountability for AI-driven decisions are crucial.\n",
      "\n",
      "**Where to Find the Latest News:**\n",
      "\n",
      "To stay truly up-to-the-minute, I'd recommend checking out:\n",
      "\n",
      "*   **Reputable Healthcare and Technology News Outlets:** Sites like Fierce Healthcare, STAT News, MobiHealthNews, Healthcare IT News, and tech publications like TechCrunch or Axios.\n",
      "*   **Medical Journals:** Major journals often publish research on AI applications in healthcare.\n",
      "*   **Industry Conferences:** Major healthcare and AI conferences are where many new developments are announced.\n",
      "\n",
      "AI in healthcare is not just a futuristic concept anymore; it's actively being implemented and researched across numerous domains, with the potential to fundamentally transform how we prevent, diagnose, and treat illness.\"\"\"\n",
      "    ),\n",
      "  ],\n",
      "  role='model'\n",
      ") grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=GenerateContentResponseUsageMetadata(\n",
      "  candidates_token_count=914,\n",
      "  prompt_token_count=41,\n",
      "  prompt_tokens_details=[\n",
      "    ModalityTokenCount(\n",
      "      modality=<MediaModality.TEXT: 'TEXT'>,\n",
      "      token_count=41\n",
      "    ),\n",
      "  ],\n",
      "  total_token_count=955\n",
      ") live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e-2bc2fb93-69b4-424c-b6b8-0b36270067d1' author='text_chat_bot' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='160626b8-fa2a-43b1-8277-c224551fc9cf' timestamp=1763508658.83268\n",
      "model_version=None content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text='Are there any new developments in drug discovery?'\n",
      "    ),\n",
      "  ],\n",
      "  role='user'\n",
      ") grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e-0e5743d4-351a-4552-a7d4-2adac8aabe0e' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='6b156046-f2ef-4d55-a73e-a0ee4d1713ef' timestamp=1763508662.503009\n",
      "model_version=None content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text=\"\"\"Yes, absolutely! Drug discovery is one of the areas where AI is having a particularly **profound and rapid impact**. Here are some of the key new developments and trends in AI-powered drug discovery:\n",
      "\n",
      "**1. Generative AI for Novel Molecule Design:**\n",
      "*   **De Novo Design:** Instead of screening existing libraries of compounds, generative AI models (like GANs or variational autoencoders) can *design entirely new molecules* from scratch that are optimized for specific properties (e.g., binding affinity to a target, solubility, low toxicity).\n",
      "*   **Targeted Design:** These models can be trained to generate molecules that fit precisely into the binding pockets of disease-causing proteins.\n",
      "*   **News:** Many AI drug discovery companies are reporting success in designing novel candidate molecules that are now entering preclinical or even early clinical trials.\n",
      "\n",
      "**2. Enhanced Target Identification and Validation:**\n",
      "*   **Multi-omics Integration:** AI can analyze vast datasets from genomics, proteomics, transcriptomics, and metabolomics to identify novel biological targets associated with diseases that might have been missed by traditional methods.\n",
      "*   **Network Biology:** AI helps in understanding complex biological pathways and identifying key nodes (targets) within these networks that can be modulated to treat a disease.\n",
      "*   **Predicting Drugability:** AI models can assess whether a newly identified target is \"drugable\" – meaning it's likely that a small molecule or biologic can effectively interact with it.\n",
      "\n",
      "**3. Accelerating Preclinical Research:**\n",
      "*   **Predicting ADMET Properties:** AI is getting much better at predicting Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties of drug candidates early in the process. This helps de-risk candidates and reduce costly failures in later stages.\n",
      "*   **In Silico Screening and Efficacy Prediction:** AI can simulate how a drug candidate might behave in biological systems, reducing the need for some initial wet-lab experiments.\n",
      "*   **Designing Better Preclinical Models:** AI can help select the most appropriate animal models or in vitro systems for testing drug candidates.\n",
      "\n",
      "**4. Optimizing Clinical Trial Design and Patient Selection:**\n",
      "*   **Predicting Trial Success:** AI can analyze historical clinical trial data and patient characteristics to predict the likelihood of success for a new trial.\n",
      "*   **Identifying Patient Subgroups:** AI can help identify specific patient populations that are most likely to respond to a particular drug, leading to more targeted and efficient clinical trials.\n",
      "*   **Synthetic Control Arms:** In some cases, AI can help generate \"synthetic\" control arms using real-world data, potentially reducing the need for large placebo groups.\n",
      "\n",
      "**5. AI for Biologics and Antibody Discovery:**\n",
      "*   **Antibody Engineering:** AI is used to design antibodies with improved binding affinity, stability, and reduced immunogenicity.\n",
      "*   **Predicting Epitopes:** AI can help predict which parts of a target protein are most likely to be recognized by an antibody.\n",
      "\n",
      "**Key Companies and Investments:**\n",
      "\n",
      "The field is seeing significant investment and activity from both established pharmaceutical giants and specialized AI drug discovery startups. Companies like **Recursion Pharmaceuticals, Exscientia, BenevolentAI, Atomwise, Insitro, and Schrödinger** are at the forefront, often partnering with larger pharma companies.\n",
      "\n",
      "**Challenges Remain:**\n",
      "\n",
      "Despite the incredible progress, challenges persist:\n",
      "*   **Data Quality and Accessibility:** High-quality, well-annotated biological data is essential for training effective AI models.\n",
      "*   **Validation:** Rigorous experimental validation is still crucial to confirm AI-generated hypotheses.\n",
      "*   **Interpretability:** Understanding *why* an AI model makes a certain prediction can still be difficult, especially for complex models.\n",
      "*   **Regulatory Acceptance:** Evolving regulatory frameworks are still adapting to AI-driven drug discovery.\n",
      "\n",
      "In summary, AI is not just an incremental improvement in drug discovery; it's a paradigm shift, enabling researchers to explore chemical and biological space in ways that were previously impossible, leading to faster, more efficient, and potentially more successful development of new medicines.\"\"\"\n",
      "    ),\n",
      "  ],\n",
      "  role='model'\n",
      ") grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=GenerateContentResponseUsageMetadata(\n",
      "  candidates_token_count=838,\n",
      "  prompt_token_count=966,\n",
      "  prompt_tokens_details=[\n",
      "    ModalityTokenCount(\n",
      "      modality=<MediaModality.TEXT: 'TEXT'>,\n",
      "      token_count=966\n",
      "    ),\n",
      "  ],\n",
      "  total_token_count=1804\n",
      ") live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e-0e5743d4-351a-4552-a7d4-2adac8aabe0e' author='text_chat_bot' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='befc8fd5-b5ff-4951-b246-5a813d49a59b' timestamp=1763508662.504779\n",
      "model_version=None content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text='Tell me more about the second development you found.'\n",
      "    ),\n",
      "  ],\n",
      "  role='user'\n",
      ") grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e-84af406b-d63e-4aee-88e2-3c2bea06b0b6' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='3ae6b0d9-4f40-4c20-b890-44dfcccf5eb8' timestamp=1763508666.787836\n",
      "model_version=None content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text=\"\"\"You're asking about the second development I mentioned: **Enhanced Target Identification and Validation**. This is a crucial area because finding the right target is the foundational step in developing any new drug. If you hit the wrong target, or a target that isn't actually involved in the disease process, your drug won't work, no matter how well-designed it is.\n",
      "\n",
      "Here's a deeper dive into how AI is revolutionizing target identification and validation:\n",
      "\n",
      "**1. Multi-omics Integration: Unraveling Biological Complexity**\n",
      "\n",
      "*   **What it is:** \"Omics\" refers to different types of large-scale biological data:\n",
      "    *   **Genomics:** Studies the complete set of genes (DNA).\n",
      "    *   **Transcriptomics:** Studies the RNA molecules produced by genes, indicating gene activity.\n",
      "    *   **Proteomics:** Studies the complete set of proteins, which are the workhorses of the cell.\n",
      "    *   **Metabolomics:** Studies the small molecules (metabolites) involved in cellular processes.\n",
      "    *   **Epigenomics:** Studies modifications to DNA that affect gene activity without changing the DNA sequence itself.\n",
      "*   **The Challenge:** Each of these datasets provides a piece of the puzzle. Individually, they can be informative, but they often don't tell the whole story. Diseases are rarely caused by a single genetic mutation; they are complex dysregulations involving multiple genes, proteins, and metabolic pathways.\n",
      "*   **AI's Role:** AI, particularly machine learning, excels at finding patterns and correlations within massive, heterogeneous datasets.\n",
      "    *   **Pattern Recognition:** AI algorithms can sift through millions of data points across genomics, transcriptomics, and proteomics to identify patterns that are consistently altered in diseased cells or tissues compared to healthy ones.\n",
      "    *   **Identifying Causal Links:** By analyzing these complex interactions, AI can help infer which alterations are most likely driving the disease (potential targets) and which are just byproducts.\n",
      "    *   **Connecting the Dots:** AI can help bridge the gap between different omics layers. For example, it might find that a specific genetic variation (genomics) leads to increased production of a particular protein (proteomics) which then disrupts a metabolic pathway (metabolomics).\n",
      "\n",
      "**2. Network Biology: Mapping Disease Pathways**\n",
      "\n",
      "*   **What it is:** Our cells function as intricate networks, with proteins interacting with each other, genes regulating protein production, and metabolites influencing these processes. Network biology aims to map these relationships.\n",
      "*   **The Challenge:** These networks are incredibly complex and dynamic. Understanding how a disease disrupts these networks and identifying key \"bottlenecks\" or \"hubs\" that, if targeted, could correct the disruption is a monumental task for human analysis alone.\n",
      "*   **AI's Role:**\n",
      "    *   **Building Comprehensive Networks:** AI can integrate vast amounts of interaction data (protein-protein interactions, gene regulatory networks, metabolic pathways) to construct detailed biological networks.\n",
      "    *   **Identifying Critical Nodes:** By analyzing the structure and dynamics of these networks, AI can pinpoint proteins or genes that are central to disease progression. Targeting these \"central\" players can have a more profound therapeutic effect.\n",
      "    *   **Predicting Off-Target Effects:** By understanding the network, AI can also help predict potential \"off-target\" effects of a drug – where hitting one target might inadvertently disrupt other, unrelated pathways, leading to side effects.\n",
      "\n",
      "**3. Predicting \"Drugability\"**\n",
      "\n",
      "*   **What it is:** A target might be biologically relevant to a disease, but it's useless for drug development if we can't actually develop a molecule that can bind to it effectively and modulate its activity. This is the concept of \"drugability.\"\n",
      "*   **The Challenge:** Predicting whether a protein has a suitable binding site for a small molecule or antibody, and whether modulating it will have the desired therapeutic outcome without causing harm, is difficult.\n",
      "*   **AI's Role:**\n",
      "    *   **Structural Analysis:** AI models can analyze the 3D structure of proteins (often predicted by AI itself, like AlphaFold) to identify potential binding pockets.\n",
      "    *   **Predicting Modulatory Effects:** AI can learn from existing drugs and their targets to predict whether modulating a particular target is likely to be beneficial or detrimental.\n",
      "    *   **Prioritization:** This helps researchers prioritize which biological targets are most promising for further drug development efforts, saving time and resources.\n",
      "\n",
      "**In essence, AI helps researchers move from a fragmented view of disease to a holistic, interconnected understanding. By integrating diverse biological data and analyzing complex biological networks, AI is enabling the identification of novel, more promising drug targets that were previously hidden or too complex to uncover.**\n",
      "\n",
      "This enhanced target identification and validation is a critical upstream step that directly feeds into the downstream AI-powered drug design and development processes we discussed earlier.\"\"\"\n",
      "    ),\n",
      "  ],\n",
      "  role='model'\n",
      ") grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=GenerateContentResponseUsageMetadata(\n",
      "  candidates_token_count=1014,\n",
      "  prompt_token_count=1816,\n",
      "  prompt_tokens_details=[\n",
      "    ModalityTokenCount(\n",
      "      modality=<MediaModality.TEXT: 'TEXT'>,\n",
      "      token_count=1816\n",
      "    ),\n",
      "  ],\n",
      "  total_token_count=2830\n",
      ") live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e-84af406b-d63e-4aee-88e2-3c2bea06b0b6' author='text_chat_bot' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='c29351fd-e5d2-4e70-a315-c6e727639ea7' timestamp=1763508666.789436\n",
      "model_version=None content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text='Who are the main companies involved in that?'\n",
      "    ),\n",
      "  ],\n",
      "  role='user'\n",
      ") grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e-3f61a5f5-5df0-4ba0-b4e5-fb1f0c7e8c4e' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='949bf917-1809-43b1-b106-ecc99d1e5d1b' timestamp=1763508670.97266\n",
      "model_version=None content=Content(\n",
      "  parts=[\n",
      "    Part(\n",
      "      text=\"\"\"When we talk about companies involved in **enhanced target identification and validation using AI**, it's a broad category because this capability is often integrated into a larger AI drug discovery platform. However, there are companies that either specialize in this aspect or have it as a core strength within their broader offerings.\n",
      "\n",
      "Here are some of the main types of companies and specific examples, keeping in mind that this field is constantly evolving with new players emerging and existing ones expanding:\n",
      "\n",
      "**1. AI-Native Drug Discovery Companies (Platform Approach)**\n",
      "\n",
      "These companies build comprehensive AI platforms that cover multiple stages of drug discovery, from target ID to preclinical candidate selection. Target ID is a fundamental part of their engine.\n",
      "\n",
      "*   **Recursion Pharmaceuticals:** They use AI to analyze vast amounts of cellular imagery (phenotypic screening) combined with omics data. They aim to understand cellular states and identify novel targets by observing how cells respond to various perturbations and potential drug compounds. Their platform is designed to discover targets and treatments simultaneously.\n",
      "*   **BenevolentAI:** They have built a knowledge graph that integrates vast amounts of scientific literature, patents, and clinical trial data. Their AI algorithms mine this graph to uncover hidden relationships between genes, proteins, diseases, and drugs, thereby identifying novel targets and biomarkers.\n",
      "*   **Exscientia:** While known for their generative AI in molecule design, Exscientia also heavily focuses on target identification and validation as part of their end-to-end platform. They use AI to understand disease biology and select optimal targets for their AI-driven drug design process.\n",
      "*   **Insitro:** This company focuses on building a data-driven drug discovery machine. They generate high-quality, large-scale biological data (multi-omics) and use machine learning to derive novel insights and identify targets, particularly in areas like neurodegeneration and oncology.\n",
      "\n",
      "**2. Specialized AI & Data Analytics Companies with Pharma Focus**\n",
      "\n",
      "Some companies focus specifically on leveraging AI for biological insights, which directly contribute to target identification.\n",
      "\n",
      "*   **BioXcel Therapeutics:** They use AI to identify novel therapeutic applications for existing drugs and to discover new drug candidates. Their AI platform analyzes vast datasets, including genomic, proteomic, and clinical data, to identify novel targets and drug mechanisms.\n",
      "*   **Relay Therapeutics:** While focusing on protein motion and dynamics, their approach inherently involves understanding how targets function at a molecular level, which is crucial for validating their role in disease and identifying druggable sites.\n",
      "\n",
      "**3. Traditional Pharmaceutical Companies (Internal R&D & Partnerships)**\n",
      "\n",
      "Major pharmaceutical companies are increasingly investing heavily in building their own internal AI capabilities or partnering with AI drug discovery firms.\n",
      "\n",
      "*   **Pfizer, Novartis, AstraZeneca, Roche, Merck, etc.:** These giants are establishing dedicated AI/ML departments, acquiring AI companies, and forming strategic alliances to leverage AI for target identification, validation, and beyond. They have the deep biological expertise and the massive historical datasets that are invaluable for training AI models.\n",
      "*   **Examples of Partnerships:** You'll often see announcements of pharma companies partnering with companies like BenevolentAI, Exscientia, or Recursion to co-discover drugs, where target identification is a key initial phase.\n",
      "\n",
      "**4. Tech Giants with Healthcare Divisions**\n",
      "\n",
      "While not always directly *discovering* targets in the traditional sense, tech giants are developing foundational AI technologies and platforms that enable this work.\n",
      "\n",
      "*   **Google (Alphabet):** Through **Google Health** and its subsidiary **Isomorphic Labs** (focused on drug discovery), they are applying AI, including foundational models like AlphaFold, to predict protein structures and understand biological mechanisms, which is critical for target identification.\n",
      "*   **Microsoft:** Provides cloud computing infrastructure and AI tools that many biotech and pharma companies use to build their own AI drug discovery platforms. They also engage in partnerships for healthcare AI.\n",
      "\n",
      "**Key Capabilities these Companies Leverage:**\n",
      "\n",
      "*   **Machine Learning Algorithms:** For pattern recognition, classification, and prediction.\n",
      "*   **Natural Language Processing (NLP):** To extract information from unstructured scientific literature.\n",
      "*   **Knowledge Graphs:** To represent and query complex relationships between biological entities.\n",
      "*   **High-Performance Computing (HPC) & Cloud Infrastructure:** To handle massive datasets and complex computations.\n",
      "*   **Data Integration Expertise:** To combine diverse data types (genomics, proteomics, imaging, clinical records, literature).\n",
      "\n",
      "It's important to note that the lines between these categories are often blurred. Many AI drug discovery companies are building end-to-end platforms, while traditional pharma companies are becoming increasingly AI-savvy. The collaboration between these entities is also a significant driver of progress in this area.\"\"\"\n",
      "    ),\n",
      "  ],\n",
      "  role='model'\n",
      ") grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=GenerateContentResponseUsageMetadata(\n",
      "  candidates_token_count=959,\n",
      "  prompt_token_count=2841,\n",
      "  prompt_tokens_details=[\n",
      "    ModalityTokenCount(\n",
      "      modality=<MediaModality.TEXT: 'TEXT'>,\n",
      "      token_count=2841\n",
      "    ),\n",
      "  ],\n",
      "  total_token_count=3800\n",
      ") live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e-3f61a5f5-5df0-4ba0-b4e5-fb1f0c7e8c4e' author='text_chat_bot' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='1341cb05-d473-4a02-b60f-0dd412348cfd' timestamp=1763508670.97898\n",
      "model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='87acb603-a521-407e-bbae-4887435cdb1e' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763508658.829886, 'end_timestamp': 1763508666.789436, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user is asking for a summary of the conversation, focusing on key information, decisions, and unresolved questions.\\n\\nThe conversation began with the user inquiring about the latest news in AI in healthcare. The AI agent provided a comprehensive overview of key areas of advancement, including drug discovery, medical imaging, personalized treatment, administrative efficiency, and AI-powered assistants. It also highlighted emerging trends like generative AI, explainable AI, and challenges such as data privacy, regulatory hurdles, and ethical considerations. The AI agent then directed the user to reputable sources for up-to-the-minute news.\\n\\nThe user then specifically asked for more information on new developments in drug discovery. The AI agent elaborated on five key areas: generative AI for molecule design, enhanced target identification/validation, accelerating preclinical research, optimizing clinical trials, and AI for biologics/antibody discovery. It also mentioned prominent companies in the field and reiterated remaining challenges.\\n\\nThe user then requested further details on the second development mentioned: \"Enhanced Target Identification and Validation.\" The AI agent provided an in-depth explanation of this area, focusing on:\\n\\n*   **Multi-omics Integration:** How AI analyzes diverse biological data (genomics, transcriptomics, proteomics, metabolomics, epigenomics) to identify patterns and causal links in disease.\\n*   **Network Biology:** How AI maps complex biological networks to identify critical disease-driving nodes and predict off-target effects.\\n*   **Predicting \"Drugability\":** How AI assesses the potential for a target to be modulated by a drug, considering structural analysis and predicting therapeutic outcomes.\\n\\nThe AI agent emphasized that enhanced target identification and validation is a foundational upstream step that improves downstream drug discovery processes.\\n\\n**Key Information & Decisions:**\\n\\n*   **AI is transforming healthcare across multiple domains, with significant impact on drug discovery.**\\n*   **Generative AI is enabling the design of novel drug molecules.**\\n*   **AI is crucial for identifying and validating new drug targets by analyzing complex biological data and networks.**\\n*   **Key companies and investments are driving innovation in AI-powered drug discovery.**\\n*   **Data quality, validation, interpretability, and regulatory acceptance remain challenges.**\\n\\n**Unresolved Questions/Tasks:**\\n\\n*   None. The conversation has been an informative exchange of information, with the user driving the depth of discussion by asking for elaboration on specific points. The AI has provided detailed explanations in response to each query.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='9df22d0f-fa69-4a42-8f4b-d2033bcfc58c' timestamp=1763508673.062786\n",
      "model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='f8817a69-1b44-4e88-8f17-5dfed97f02f0' author='user' actions='compacted_content' long_running_tool_ids=set() branch=None id='c93d60de-a3f2-4394-b217-4f1bdcdeb7d1' timestamp=1763508678.759773\n"
     ]
    }
   ],
   "source": [
    "for event in final_session.events:\n",
    "  print(event)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "1d67c222",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "======Searching for Compaction Summary Event =======\n",
      "FOUND THE COMPACTION EVENT:\n",
      "Author: user\n",
      "Compacted Information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='87acb603-a521-407e-bbae-4887435cdb1e' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763508658.829886, 'end_timestamp': 1763508666.789436, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user is asking for a summary of the conversation, focusing on key information, decisions, and unresolved questions.\\n\\nThe conversation began with the user inquiring about the latest news in AI in healthcare. The AI agent provided a comprehensive overview of key areas of advancement, including drug discovery, medical imaging, personalized treatment, administrative efficiency, and AI-powered assistants. It also highlighted emerging trends like generative AI, explainable AI, and challenges such as data privacy, regulatory hurdles, and ethical considerations. The AI agent then directed the user to reputable sources for up-to-the-minute news.\\n\\nThe user then specifically asked for more information on new developments in drug discovery. The AI agent elaborated on five key areas: generative AI for molecule design, enhanced target identification/validation, accelerating preclinical research, optimizing clinical trials, and AI for biologics/antibody discovery. It also mentioned prominent companies in the field and reiterated remaining challenges.\\n\\nThe user then requested further details on the second development mentioned: \"Enhanced Target Identification and Validation.\" The AI agent provided an in-depth explanation of this area, focusing on:\\n\\n*   **Multi-omics Integration:** How AI analyzes diverse biological data (genomics, transcriptomics, proteomics, metabolomics, epigenomics) to identify patterns and causal links in disease.\\n*   **Network Biology:** How AI maps complex biological networks to identify critical disease-driving nodes and predict off-target effects.\\n*   **Predicting \"Drugability\":** How AI assesses the potential for a target to be modulated by a drug, considering structural analysis and predicting therapeutic outcomes.\\n\\nThe AI agent emphasized that enhanced target identification and validation is a foundational upstream step that improves downstream drug discovery processes.\\n\\n**Key Information & Decisions:**\\n\\n*   **AI is transforming healthcare across multiple domains, with significant impact on drug discovery.**\\n*   **Generative AI is enabling the design of novel drug molecules.**\\n*   **AI is crucial for identifying and validating new drug targets by analyzing complex biological data and networks.**\\n*   **Key companies and investments are driving innovation in AI-powered drug discovery.**\\n*   **Data quality, validation, interpretability, and regulatory acceptance remain challenges.**\\n\\n**Unresolved Questions/Tasks:**\\n\\n*   None. The conversation has been an informative exchange of information, with the user driving the depth of discussion by asking for elaboration on specific points. The AI has provided detailed explanations in response to each query.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='9df22d0f-fa69-4a42-8f4b-d2033bcfc58c' timestamp=1763508673.062786\n"
     ]
    }
   ],
   "source": [
    "print(\"======Searching for Compaction Summary Event =======\")\n",
    "found_summary = False #flag\n",
    "for event in final_session.events:\n",
    "  #compaction events have a 'compaction' attribute\n",
    "  if event.actions and event.actions.compaction:\n",
    "    print(\"FOUND THE COMPACTION EVENT:\")\n",
    "    print(F\"Author: {event.author}\")\n",
    "    print(f\"Compacted Information: {event}\")\n",
    "    found_summary = True\n",
    "    break\n",
    "\n",
    "if not found_summary:\n",
    "  print(\"No compaction event found.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c1565eeb",
   "metadata": {},
   "source": [
    "### Working with Session State\n",
    "\n",
    "#### Creating custom tools for Session State management\n",
    "#### Identifying `transferable characteristic` , like user's name and their country, also creating toold to capture and same it.\n",
    "\n",
    "The username is a perfect example of information that:\n",
    "\n",
    "- Is introduced once but referenced multiple times\n",
    "- Should persist throughout a conversation\n",
    "- Represents a user-specific characteristic that enhances personalization\n",
    "\n",
    "Here, for demo purposes, i'll create two tools that can store and retrieve user name and country from the Session State. **Note that all tools have access to the `ToolContext` object.**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "288fddf8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Tools created\n"
     ]
    }
   ],
   "source": [
    "#Define scope levels for state keys(following best practises)\n",
    "USER_NAME_SCORE_LEVELS=(\"temp\",\"user\",\"app\")\n",
    "\n",
    "\n",
    "#This demonstrates how tools can write to session state using tool_context.\n",
    "#The 'user:' prefix indicates this is user-specific data.\n",
    "\n",
    "def save_userinfo(\n",
    "    tool_context: ToolContext, user_name: str, country: str\n",
    ") -> Dict[str, Any]:\n",
    "    \"\"\"\n",
    "    Tool to record and save user name and country in session state.\n",
    "\n",
    "    Args:\n",
    "        user_name: The username to store in session state\n",
    "        country: The name of the user's country\n",
    "    \"\"\"\n",
    "    # Write to session state using the 'user:' prefix for user data\n",
    "    tool_context.state[\"user:name\"]=user_name\n",
    "    tool_context.state[\"user:country\"]=country\n",
    "    return {\"status\": \"success\"}\n",
    "\n",
    "\n",
    "#This demonstrates how tools can read from session state.\n",
    "def retrieve_userinfo(tool_context: ToolContext)-> Dict[str,Any]:\n",
    "    \"\"\"\n",
    "    Tool to retrieve user name and country from session state.\n",
    "    \"\"\"\n",
    "\n",
    "    #Read from session state\n",
    "    user_name=tool_context.state.get(\"user:name\",\"Username not found.\")\n",
    "    country=tool_context.state.get(\"user:country\",\"Country not found\")\n",
    "    return {\"status\":\"success\",\"user_name\":user_name,\"country\":country}\n",
    "\n",
    "print(\"Tools created\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a640d657",
   "metadata": {},
   "source": [
    "#### Creating an Agent with Session State tools"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "ed8d75b6",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"default\", but the root agent was loaded from \"/Users/liakooras/Desktop/UDEMIES/genAiKaggle/.conda/lib/python3.12/site-packages/google/adk/agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Agent with session state tools initialized!\n"
     ]
    }
   ],
   "source": [
    "#config\n",
    "APP_NAME=\"default\"\n",
    "USER_ID=\"default\"\n",
    "MODEL_NAME=\"gemini-2.5-flash-lite\"\n",
    "\n",
    "root_agent=LlmAgent(\n",
    "  model=Gemini(model=MODEL_NAME,retry_options=retry_config),\n",
    "  name=\"text_chat_bot\",\n",
    "  description=\"\"\"A text chatbot.\n",
    "    Tools for managing user context:\n",
    "    * To record username and country when provided use `save_userinfo` tool.\n",
    "    * To fetch username and country when required use `retrieve_userinfo` tool.\n",
    "    \"\"\",\n",
    "    tools=[save_userinfo,retrieve_userinfo]\n",
    ")\n",
    "\n",
    "session_service = InMemorySessionService()\n",
    "runner = Runner(agent=root_agent,session_service=session_service,app_name=\"default\")\n",
    "\n",
    "print(\"Agent with session state tools initialized!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "62c7db17",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### SESSION: state-demo\n",
      "\n",
      " User > Hi there, how are you doing today? What is my name?\n",
      "gemini-2.5-flash-lite >  Hello! I'm doing great. I'm not sure what your name is, though. Can you tell me? \n",
      "\n",
      "\n",
      " User > My name is Ilias, Im from Greece\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "gemini-2.5-flash-lite >  Nice to meet you, Ilias! I've saved your information.\n",
      "\n",
      " User > What is my name? Where do i come from?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "gemini-2.5-flash-lite >  Your name is Ilias and you come from Greece.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "  runner,\n",
    "  [\n",
    "    \"Hi there, how are you doing today? What is my name?\",# Agent shouldn't know the name yet\n",
    "    \"My name is Ilias, Im from Greece\",# Provide name - agent should save it\n",
    "    \"What is my name? Where do i come from?\"# Agent should recall from session state\n",
    "  ],\n",
    "  \"state-demo\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "cc003ef0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Session State Contents:\n",
      "{'user:name': 'Ilias', 'user:country': 'Greece'}\n",
      "\n",
      " The 'user:name' and 'user:country' keys are storing the data.\n"
     ]
    }
   ],
   "source": [
    "#inspecting session state\n",
    "\n",
    "#retrieve the session and inspect its state\n",
    "\n",
    "session = await session_service.get_session(\n",
    "  app_name=APP_NAME,user_id=USER_ID, session_id=\"state-demo\"\n",
    ")\n",
    "\n",
    "print(\"Session State Contents:\")\n",
    "print(session.state)\n",
    "print(\"\\n The 'user:name' and 'user:country' keys are storing the data.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "id": "fab5c9bf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"Hello! I'm doing great. I'm not sure what your name is, though. Can you tell me? \\n\""
      ]
     },
     "execution_count": 122,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "session.events[1].content.parts[0].text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "id": "26f3f2db",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'id': 'state-demo',\n",
       " 'app_name': 'default',\n",
       " 'user_id': 'default',\n",
       " 'state': {'user:name': 'Ilias', 'user:country': 'Greece'},\n",
       " 'events': [Event(model_version=None, content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        text='Hi there, how are you doing today? What is my name?'\n",
       "      ),\n",
       "    ],\n",
       "    role='user'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-164cd67f-7dab-47cd-940a-866dabf3bc77', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=None, branch=None, id='5d6a11f1-7f88-490a-aa9f-a0b5c408e1be', timestamp=1763545908.011399),\n",
       "  Event(model_version='gemini-2.5-flash-lite', content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        text=\"\"\"Hello! I'm doing great. I'm not sure what your name is, though. Can you tell me? \n",
       "  \"\"\"\n",
       "      ),\n",
       "    ],\n",
       "    role='model'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=<FinishReason.STOP: 'STOP'>, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
       "    candidates_token_count=25,\n",
       "    prompt_token_count=222,\n",
       "    prompt_tokens_details=[\n",
       "      ModalityTokenCount(\n",
       "        modality=<MediaModality.TEXT: 'TEXT'>,\n",
       "        token_count=222\n",
       "      ),\n",
       "    ],\n",
       "    total_token_count=247\n",
       "  ), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-164cd67f-7dab-47cd-940a-866dabf3bc77', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=None, branch=None, id='58a6c5fc-84fb-4f74-b369-265a51808cbc', timestamp=1763545908.015035),\n",
       "  Event(model_version=None, content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        text='My name is Ilias, Im from Greece'\n",
       "      ),\n",
       "    ],\n",
       "    role='user'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-0eca0b96-91f0-43ad-989e-b755510f64ed', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=None, branch=None, id='2d8d5784-fed3-45be-8375-861352bbcedc', timestamp=1763545908.749206),\n",
       "  Event(model_version='gemini-2.5-flash-lite', content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        function_call=FunctionCall(\n",
       "          args={\n",
       "            'country': 'Greece',\n",
       "            'user_name': 'Ilias'\n",
       "          },\n",
       "          id='adk-d147ae31-c2ca-4361-a5d2-84ac532ab151',\n",
       "          name='save_userinfo'\n",
       "        )\n",
       "      ),\n",
       "    ],\n",
       "    role='model'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=<FinishReason.STOP: 'STOP'>, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
       "    candidates_token_count=24,\n",
       "    prompt_token_count=260,\n",
       "    prompt_tokens_details=[\n",
       "      ModalityTokenCount(\n",
       "        modality=<MediaModality.TEXT: 'TEXT'>,\n",
       "        token_count=260\n",
       "      ),\n",
       "    ],\n",
       "    total_token_count=284\n",
       "  ), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-0eca0b96-91f0-43ad-989e-b755510f64ed', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='1e83532d-9251-42b1-893d-d4fd0e663c3f', timestamp=1763545908.749601),\n",
       "  Event(model_version=None, content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        function_response=FunctionResponse(\n",
       "          id='adk-d147ae31-c2ca-4361-a5d2-84ac532ab151',\n",
       "          name='save_userinfo',\n",
       "          response={\n",
       "            'status': 'success'\n",
       "          }\n",
       "        )\n",
       "      ),\n",
       "    ],\n",
       "    role='user'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-0eca0b96-91f0-43ad-989e-b755510f64ed', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={'user:name': 'Ilias', 'user:country': 'Greece'}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=None, branch=None, id='29d6ddc8-a8c5-46d3-b310-b9b95e145a91', timestamp=1763545909.181168),\n",
       "  Event(model_version='gemini-2.5-flash-lite', content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        text=\"Nice to meet you, Ilias! I've saved your information.\"\n",
       "      ),\n",
       "    ],\n",
       "    role='model'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=<FinishReason.STOP: 'STOP'>, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
       "    candidates_token_count=15,\n",
       "    prompt_token_count=300,\n",
       "    prompt_tokens_details=[\n",
       "      ModalityTokenCount(\n",
       "        modality=<MediaModality.TEXT: 'TEXT'>,\n",
       "        token_count=300\n",
       "      ),\n",
       "    ],\n",
       "    total_token_count=315\n",
       "  ), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-0eca0b96-91f0-43ad-989e-b755510f64ed', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=None, branch=None, id='c770c82e-2238-49ab-ae62-bcad67ce70e9', timestamp=1763545909.182019),\n",
       "  Event(model_version=None, content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        text='What is my name? Where do i come from?'\n",
       "      ),\n",
       "    ],\n",
       "    role='user'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-ad717ec6-d558-463d-a24c-70e573e8608e', author='user', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=None, branch=None, id='30a17a0e-ee1b-4bad-b7f5-a55f542e9424', timestamp=1763545909.707327),\n",
       "  Event(model_version='gemini-2.5-flash-lite', content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        function_call=FunctionCall(\n",
       "          args={},\n",
       "          id='adk-4579d28d-2964-4e02-a93f-b7702c77d007',\n",
       "          name='retrieve_userinfo'\n",
       "        )\n",
       "      ),\n",
       "    ],\n",
       "    role='model'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=<FinishReason.STOP: 'STOP'>, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
       "    candidates_token_count=11,\n",
       "    prompt_token_count=328,\n",
       "    prompt_tokens_details=[\n",
       "      ModalityTokenCount(\n",
       "        modality=<MediaModality.TEXT: 'TEXT'>,\n",
       "        token_count=328\n",
       "      ),\n",
       "    ],\n",
       "    total_token_count=339\n",
       "  ), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-ad717ec6-d558-463d-a24c-70e573e8608e', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=set(), branch=None, id='750e3c99-c9d9-4032-809c-76285a118e00', timestamp=1763545909.707719),\n",
       "  Event(model_version=None, content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        function_response=FunctionResponse(\n",
       "          id='adk-4579d28d-2964-4e02-a93f-b7702c77d007',\n",
       "          name='retrieve_userinfo',\n",
       "          response={\n",
       "            'country': 'Greece',\n",
       "            'status': 'success',\n",
       "            'user_name': 'Ilias'\n",
       "          }\n",
       "        )\n",
       "      ),\n",
       "    ],\n",
       "    role='user'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=None, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=None, live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-ad717ec6-d558-463d-a24c-70e573e8608e', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=None, branch=None, id='c1813e43-12cc-4ca5-b063-9e343853cb22', timestamp=1763545910.110009),\n",
       "  Event(model_version='gemini-2.5-flash-lite', content=Content(\n",
       "    parts=[\n",
       "      Part(\n",
       "        text='Your name is Ilias and you come from Greece.'\n",
       "      ),\n",
       "    ],\n",
       "    role='model'\n",
       "  ), grounding_metadata=None, partial=None, turn_complete=None, finish_reason=<FinishReason.STOP: 'STOP'>, error_code=None, error_message=None, interrupted=None, custom_metadata=None, usage_metadata=GenerateContentResponseUsageMetadata(\n",
       "    candidates_token_count=11,\n",
       "    prompt_token_count=370,\n",
       "    prompt_tokens_details=[\n",
       "      ModalityTokenCount(\n",
       "        modality=<MediaModality.TEXT: 'TEXT'>,\n",
       "        token_count=370\n",
       "      ),\n",
       "    ],\n",
       "    total_token_count=381\n",
       "  ), live_session_resumption_update=None, input_transcription=None, output_transcription=None, avg_logprobs=None, logprobs_result=None, cache_metadata=None, citation_metadata=None, invocation_id='e-ad717ec6-d558-463d-a24c-70e573e8608e', author='text_chat_bot', actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction=None, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None), long_running_tool_ids=None, branch=None, id='b92b86a6-de91-4792-9abe-ac0d97f85c94', timestamp=1763545910.110567)],\n",
       " 'last_update_time': 1763545910.110567}"
      ]
     },
     "execution_count": 134,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vars(session)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "id": "1893cc99",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### SESSION: new-isolated-session\n",
      "\n",
      " User > Hi there, how are you doing today? What is my name?\n",
      "gemini-2.5-flash-lite >  Hello! I'm doing great, thank you for asking. I'd love to tell you your name, but I don't have access to that information right now. To do that, I'd need you to tell me your name and country first.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Start a completely new session - the agent won't know my name\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\"Hi there, how are you doing today? What is my name?\"],\n",
    "    \"new-isolated-session\",\n",
    ")\n",
    "\n",
    "# Expected: The agent won't know the name because this is a different session"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "id": "531ebf2d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "New Session State:\n",
      "{'user:name': 'Ilias', 'user:country': 'Greece'}\n"
     ]
    }
   ],
   "source": [
    "# Check the state of the new session\n",
    "session = await session_service.get_session(\n",
    "    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n",
    ")\n",
    "\n",
    "print(\"New Session State:\")\n",
    "print(session.state)\n",
    "\n",
    "# Note: Depending on implementation, you might see shared state here.\n",
    "# This is where the distinction between session-specific and user-specific state becomes important.\n",
    "\n",
    "#session_id => new session\n",
    "#user_id => same person\n",
    "#app_name => same App\n",
    "# Its like you are the same user in the same app, you have this user state"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "09f3a3fd",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
